Processing 00000000.tx.1: Subcellular Distribution and Turnover of Presenilins in Transfected Cells* Jimin Zhang, David E. 

Phrase: "Subcellular Distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "Turnover of Presenilins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031227:turnover [Quantitative Concept]
   790   C0243127:turnover [Functional Concept]
   790   C0443331:Turnover [Health Care Activity]

Phrase: "in Transfected Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "* Jimin Zhang,"

Phrase: "David E."
Processing 00000000.tx.2: Kang, Weiming Xia, Masayasu Okochi, Hiroshi Mori, Dennis J. 

Phrase: "Kang,"

Phrase: "Weiming Xia,"

Phrase: "Masayasu Okochi,"

Phrase: "Hiroshi Mori,"

Phrase: "Dennis J."
Processing 00000000.tx.3: Selkoe, and Edward H. 

Phrase: "Selkoe,"

Phrase: "and"

Phrase: "Edward H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Koo** From the Departments of Neurology and Pathology, Harvard Medical School and Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115,the Department of Neurosciences, University of California San Diego, La Jolla, California 92093,and the Department of Molecular Biology, Tokyo Institute of Psychiatry, Tokyo 156,Japan  ABSTRACT Top Abstract Introduction Materials & Methods Results Discussion References The mechanisms by which mutations in presenilin-1 (PS1) and presenilin-2 (PS2) result in the Alzheimer's disease phenotype are unclear. 

Phrase: "Koo"

Phrase: "*"

Phrase: "*"

Phrase: "From the Departments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704729:Department [Organization]

Phrase: "of Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "and"

Phrase: "Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Center for Neurologic Diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Brigham and Women's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0043210:Women [Population Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02115,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "the Department of Neurosciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University of California San Diego,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0006754:California [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C1826357:San [Gene or Genome]
   804   C3146274:California [Plant]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "California 92093,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: "and"

Phrase: "the Department of Molecular Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Tokyo Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Tokyo 156,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040371:Tokyo [Geographic Area]

Phrase: "Japan  ABSTRACT Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The mechanisms by which mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "in presenilin-1 (PS1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin-2 (PS2) result in the Alzheimer's disease phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.5: Full-length PS1 and PS2 are each processed into stable proteolytic fragments after their biosynthesis in transfected cells. 

Phrase: "Full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "each"

Phrase: "processed into stable proteolytic fragments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0205360:Stable [Qualitative Concept]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C0597304:Proteolytic [Molecular Function]
   760   C1522240:Processed [Phenomenon or Process]
   760   C1547311:Stable [Intellectual Product]
   760   C1947941:proteolytic [Enzyme]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "after their biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: PS1 and PS2 have been localized by immunocytochemistry to the endoplasmic reticulum (ER) and Golgi compartments, but previous studies could not differentiate between the full-length presenilin proteins and their fragments. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "localized by immunocytochemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242349:Immunocytochemistry [Laboratory Procedure]
   790   C0392752:Localized [Spatial Concept]

Phrase: "to the endoplasmic reticulum (ER)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi compartments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "but"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differentiate between the full-length presenilin proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205615:differentiate [Qualitative Concept]
   748   C0443225:Full [Qualitative Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "their fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.7: We carried out subcellular fractionation of cells stably transfected with PS1 or PS2 to determine the localization of full-length presenilins and their fragments. 

Phrase: "We"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out subcellular fractionation of cells stably"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1656251:subcellular fractionation [Laboratory Procedure]
   767   C0007593:Cell Fractionation [Laboratory Procedure]
   753   C0016640:fractionation [Laboratory Procedure]
   753   C0524811:fractionation [Therapeutic or Preventive Procedure]
   753   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "transfected with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "PS2 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418986:PRESENILIN 2 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "determine"

Phrase: "the localization of full-length presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "their fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.8: Full-length PS1 and PS2 were principally distributed in ER fractions, whereas the N- and C-terminal fragments were localized predominantly to the Golgi fractions. 

Phrase: "Full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "principally"

Phrase: "distributed in ER fractions,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1704711:Distributed [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "whereas"

Phrase: "the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "predominantly to the Golgi fractions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0018042:Golgi [Cell Component]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.9: In cells expressing the PS1 mutant lacking exon 9(E9), we observed only full-length molecules that were present in the ER and Golgi fractions. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the PS1 mutant lacking exon 9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PRESENILIN 1 [Gene or Genome]
   799   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0332268:Lacking [Qualitative Concept]
   799   C0596988:Mutant [Cell or Molecular Dysfunction]
   799   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(E9"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only full-length molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "present in the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "Golgi fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.10: The turnover rate was considerably slower for the E9 holoprotein, apparently due to decreased degradation within the ER. 

Phrase: "The turnover rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "considerably slower for the E9 holoprotein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439834:Slow [Qualitative Concept]

Phrase: "apparently due to decreased degradation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0205216:Decreased [Quantitative Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0699900:Degradation [Organism Function]
   760   C0750541:apparently [Idea or Concept]
   760   C3146286:Due [Idea or Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "within the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.11: Our results suggest that that full-length presenilin proteins are primarily ER resident molecules and undergo endoproteolysis within the ER. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "that full-length presenilin proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "primarily ER resident molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0567416:molecules [Substance]
   721 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "undergo"

Phrase: "endoproteolysis within the ER."
Processing 00000000.tx.12: The fragments are subsequently transported to the Golgi compartment, where their turnover rate is much slower than that of the full-length presenilin in the ER.  

Phrase: "The fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "subsequently"

Phrase: "transported to the Golgi compartment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1550030:Transport To [Idea or Concept]
   760   C0018042:Golgi [Cell Component]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]
   726   C0005528:Transport, NOS [Cell Function]
   726   C1317949:Transport [Manufactured Object]
   726   C3495449:transport [Medical Device]

Phrase: "where"

Phrase: "their turnover rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "much slower than that of the full-length presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0439834:Slow [Qualitative Concept]

Phrase: "in the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.13: INTRODUCTION Top Abstract Introduction Materials & Methods Results Discussion References Alzheimer's disease (AD),1 the major age-related dementing disorder, usually occurs sporadically in the elderly population. 

Phrase: "INTRODUCTION Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD),1"

Phrase: "the major age-related dementing disorder,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0012634:Disorder [Disease or Syndrome]

Phrase: "usually"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "sporadically in the elderly population."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001792:Elderly [Population Group]
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C1999167:elderly [Population Group]
Processing 00000000.tx.14: In a subset of cases, familial AD (FAD) occurs as an inherited autosomal dominant disease. 

Phrase: "In a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "familial AD (FAD)"

Phrase: "occurs as an inherited autosomal dominant disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0443147:Autosomal dominant [Intellectual Product]
   774   C0019247:Inherited disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0439660:Inherited [Functional Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1527180:Dominant [Functional Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.15: Mutations in three different genes are associated with the familial form of AD (reviewed in Ref. 1). 

Phrase: "Mutations in three different genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with the familial form of AD ("
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1832428:Familial form [Finding]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.16: The first FAD gene is the -amyloid precursor protein (APP), the precursor to amyloid -protein, the major component of senile plaques seen in brains of AD individuals. 

Phrase: "The first FAD gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "the -amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "the precursor to amyloid -protein,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "the major component of senile plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "seen in brains of AD individuals."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0205397:Seen [Qualitative Concept]
   719   C0027361:Individual [Population Group]
   719 E C0042789:see [Organism Function]
   719   C0237401:Individual [Human]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C1947903:See [Activity]
Processing 00000000.tx.17: The other genes, presenilin 1(PS1) on chromosome 14(2) and presenilin 2(PS2) on chromosome 1(3, 4), account for the majority of the early onset cases of FAD. 

Phrase: "The"

Phrase: "other genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "on chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008656:Chromosome 14 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "account for the majority of the early onset cases of FAD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1551359:account [Idea or Concept]
   736   C2741673:Account # [Clinical Attribute]
   736   C2981730:Account [Classification]
Processing 00000000.tx.18: PS1 and PS2, which are functionally homologous to the C.elegans Sel-12 molecule (5, 6), are hydrophobic proteins that cross the membrane 6-8 times (7, 8). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "which"

Phrase: "are"

Phrase: "functionally homologous to the C.elegans Sel-12 molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1334043:Homologous [Gene or Genome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "hydrophobic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "the membrane 6-8 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.19: In transfected cells, both PS1 and PS2 holoprotein are rapidly turned over with a half-life of under 1h (9, 10). 

Phrase: "In transfected cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "both PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2 holoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "are"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "over with a half-life of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018517:Half-Life [Temporal Concept]
   753   C0205136:Over [Spatial Concept]
   753   C0376558:Life [Idea or Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "under 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.20: However, in transfected cells and in brain tissue, stable N- (NTF) and C-terminal fragments (CTF) are apparently generated by endoproteolysis from full-length presenilin molecules (9, 11, 12). 

Phrase: "However,"

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and in brain tissue,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0440746:Brain tissue [Tissue]
   833   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "stable N- (NTF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "C-terminal fragments (CTF)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "generated by endoproteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "from full-length presenilin molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "(9,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.21: Immunolocalization studies of presenilins in transfected cells have demonstrated a predominant endoplasmic reticulum (ER) and Golgi distribution (13, 14). 

Phrase: "Immunolocalization"

Phrase: "studies of presenilins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0557651:Study [Manufactured Object]
   790   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "a predominant endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "(ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "Golgi distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.22: The localization pattern is similar regardless of whether the antibodies are generated to either N- or C-terminal epitopes, raising the possibility that the NTFs and CTFs remain in proximity to each other. 

Phrase: "The localization pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "similar regardless of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "whether"

Phrase: "the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "generated to either N-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3146294:Generated [Activity]

Phrase: "or"

Phrase: "C-terminal epitopes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003316:Epitopes [Immunologic Factor]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the NTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTFs"

Phrase: "remain in proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514583:Proximity [Spatial Concept]

Phrase: "to each other."
Processing 00000000.tx.23: However, these studies cannot distinguish the full-length presenilin molecules from the stable fragments. 

Phrase: "However,"

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "cannot"

Phrase: "distinguish"

Phrase: "the full-length presenilin molecules from the stable fragments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0314668:Stable molecule [Molecular Function]
   742   C0567416:molecules [Substance]
Processing 00000000.tx.24: APP is also located in the ER and Golgi, where direct or indirect interaction with the presenilins may contribute to the production of longer forms of amyloid -peptide (A) (15-17). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "located in the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Golgi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "where"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "indirect interaction with the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "contribute to the production of longer forms of amyloid -peptide"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0033268:production [Occupational Activity]
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1880177:Contribute [Activity]
   706   C0205166:Long [Qualitative Concept]
   706 E C1522492:Form [Functional Concept]
   706   C1706317:Long [Qualitative Concept]

Phrase: "(A"

Phrase: "A"

Phrase: ")"

Phrase: "(15-17"

Phrase: ")."
Processing 00000000.tx.25: Thus, knowledge of the processing and trafficking of presenilin molecules is important to our understanding of the pathways of A production. 

Phrase: "Thus,"

Phrase: "knowledge of the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0376554:Knowledge [Intellectual Product]

Phrase: "and"

Phrase: "trafficking of presenilin molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0567416:molecules [Substance]
   770   C0599896:trafficking [Cell Function]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "important to our understanding of the pathways of A"

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.26: The role of endoproteolysis in presenilin maturation and function remains to be defined. 

Phrase: "The role of endoproteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in presenilin maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.27: Interestingly, a PS1 FAD mutation lacking exon 9(E9) that results in the absence of conventional endoproteolysis (12) can nevertheless functionally replace an egg-laying defect resulting from a C.elegans sel-12 mutant (5). 

Phrase: "Interestingly,"

Phrase: "a PS1 FAD mutation lacking exon 9"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   812   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PRESENILIN 1 [Gene or Genome]
   793   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0015576:familial [Family Group]
   793   C0026882:Mutation [Genetic Function]
   793   C0241888:Familial [Functional Concept]
   793   C0332268:Lacking [Qualitative Concept]
   793   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]
   721 E C1704727:Family [Conceptual Entity]

Phrase: "(E9"

Phrase: ")"

Phrase: "that"

Phrase: "results in the absence of conventional endoproteolysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332197:absence [Quantitative Concept]
   748   C0439858:Conventional [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2825142:Result [Finding]

Phrase: "(12"

Phrase: ")"

Phrase: "can"

Phrase: "nevertheless functionally"

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "an egg-laying defect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]
   734   C0029957:egg-laying [Organism Function]
   734   C1622979:Egg Laying [Organism Function]

Phrase: "resulting from a C.elegans sel-12 mutant"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C0678226:resulting [Functional Concept]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.28: To date, neither the subcellular distribution of the holoprotein and its fragments nor the compartment where endoproteolytic cleavage occurs is known. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "neither"

Phrase: "the subcellular distribution of the holoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "its fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "nor"

Phrase: "the compartment where endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "is"

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.29: To define the distribution of full-length forms and stable fragments of PS1 and PS2, we carried out subcellular fractionation of stably transfected cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the distribution of full-length forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "stable fragments of PS1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "PS2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "we"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out subcellular fractionation of stably transfected cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1656251:subcellular fractionation [Laboratory Procedure]
   757   C0007593:Cell Fractionation [Laboratory Procedure]
   748   C0016640:fractionation [Laboratory Procedure]
   748   C0524811:fractionation [Therapeutic or Preventive Procedure]
   748   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.30: Our results indicate that full-length PS1 and PS2 are located mainly in the ER, while their N- and C-terminal fragments are located principally in the Golgi. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "located"

Phrase: "mainly in the ER,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "while"

Phrase: "their N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "located"

Phrase: "principally in the Golgi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018042:Golgi [Cell Component]
Processing 00000000.tx.31: Turnover rate of the E9 mutant PS1 protein was slower than wild type (WT) PS1 holoprotein. 

Phrase: "Turnover rate of the E9 mutant PS1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "slower than wild type (WT) PS1 holoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0439834:Slow [Qualitative Concept]
Processing 00000000.tx.32: Concomitantly, the steady state subcellular distribution of E9 PS1 extends to both ER and Golgi fractions. 

Phrase: "Concomitantly,"

Phrase: "the steady state subcellular distribution of E9 PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "extends to both ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0231448:Extend [Functional Concept]
   760   C0439792:extend [Spatial Concept]

Phrase: "and"

Phrase: "Golgi fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.33: Finally, pulse-chase experiments combined with subcellular fractionation suggested that the endoproteolytic cleavage of PS1 takes place in the ER.  

Phrase: "Finally,"

Phrase: "pulse-chase experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "combined with subcellular fractionation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1656251:subcellular fractionation [Laboratory Procedure]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0205195:Combined [Qualitative Concept]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the endoproteolytic cleavage of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in the ER."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442504:Place [Spatial Concept]
   760   C1704765:Place [Functional Concept]
   760   C1882509:Place [Activity]
   760   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.34: MATERIALS AND METHODS Top Abstract Introduction Materials & Methods Results Discussion References PS1 and PS2 Stably Transfected Cells-- Chinese hamster ovary (CHO) cells stably transfected with WT or mutant (M146L or C410Y) PS1, or with WT or mutant (N141I) PS2 were described previously (10, 17). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2 Stably Transfected Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "Chinese hamster ovary (CHO) cells stably"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   904   C0085080:Chinese Hamster Ovary Cell [Cell]
   840   C0018555:Chinese Hamster [Mammal]
   804   C0007634:Cells [Cell]
   804   C0008120:chinese [Language]
   804   C0018557:Hamster [Mammal]
   804   C0029939:Ovary [Body Part, Organ, or Organ Component]
   804   C0152035:Chinese [Population Group]
   804   C0227898:ovary [Body Part, Organ, or Organ Component]
   804   C1278992:Ovary [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(M146L"

Phrase: "or"

Phrase: "C410Y"

Phrase: ")"

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or with WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(N141I"

Phrase: ")"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.35: cDNAs encoding WT and E9 PS1 were subcloned into an ecdysone-inducible mammalian expression vector (pIND, Invitrogen) and transfected into human embryonic kidney 293cells previously transfected with the pVgRXR construct that encodes the regulatory ecdysone receptor (EcR293, Invitrogen). 

Phrase: "cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "E9 PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "subcloned into an ecdysone-inducible mammalian expression vector"

Phrase: "("

Phrase: "pIND"

Phrase: ","

Phrase: "Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "transfected into human embryonic kidney 293cells previously"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]

Phrase: "transfected with the pVgRXR"

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the regulatory ecdysone receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0058913:ecdysone receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(EcR293,"

Phrase: "Invitrogen"

Phrase: ")."
Processing 00000000.tx.36: Stable cell lines were selected for Zeocin and G418 resistance. 

Phrase: "Stable cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   983   C0598091:stable cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "selected for Zeocin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0537913:Zeocin [Amino Acid, Peptide, or Protein]
   756   C1707391:Select [Activity]

Phrase: "and"

Phrase: "G418 resistance."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.37: PS1 expression was induced by overnight treatment with 0.0625-1.0 M muristerone A. 

Phrase: "PS1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "was"

Phrase: "induced by overnight treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205263:Induced [Functional Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 0.0625-1.0 M muristerone A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0369637:M not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.38: Antibodies-- PS1 polyclonal antibodies J27 and 4627were raised against residues 27-42 and 457-467 of PS1, respectively, and have been previously characterized (9, 10). 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "--"

Phrase: "PS1 polyclonal antibodies J27"

Phrase: "and"

Phrase: "4627were"

Phrase: "raised against residues 27-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442818:Raised [Quantitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "457-467 of PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively,"

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.39: The PS1 monoclonal antibody, PSN2, was generated against a synthetic peptide corresponding to residues 31-56 of PS1 (18). 

Phrase: "The PS1 monoclonal antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "PSN2,"

Phrase: "was"

Phrase: "generated against a synthetic peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1883254:synthetic [Activity]
   760   C3146294:Generated [Activity]

Phrase: "corresponding to residues 31-56 of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0450355:31 [Intellectual Product]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.40: A PS2 polyclonal antibody, 1209, was raised against a glutathione S-transferase bacterial fusion protein encompassing residues 1-70 of PS2. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A PS2 polyclonal antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "1209,"

Phrase: "was"

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "against a glutathione S-transferase bacterial fusion protein encompassing residues 1-70"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   821   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   813   C0004627:Protein, Bacterial [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332466:Fusion [Functional Concept]
   790   C0521009:Bacterial [Qualitative Concept]
   790   C1293131:Fusion [Therapeutic or Preventive Procedure]
   756   C1709915:Residue [Conceptual Entity]
   756   C1882936:RESIDUE [Phenomenon or Process]
   718 E C0004611:Bacteria [Bacterium]
   718 E C1510439:bacteria [Functional Concept]
   718 E C2347473:% Bacteria [Quantitative Concept]
   706 E C1609982:Residual [Qualitative Concept]

Phrase: "of PS2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.41: Polyclonal antibody CT15 was raised against the last 15residues at the C terminus of the APP (19). 

Phrase: "Polyclonal antibody CT15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412189:CT15 [Gene or Genome]
   734   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "raised against the last 15residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442818:Raised [Quantitative Concept]

Phrase: "at the C terminus"

Phrase: "of the APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.42: Additional polyclonal antibodies included calnexin (StressGen) and rat Na+/K+-ATPase (Upstate Biotechnology, Inc., Lake Placid, NY), plus a monoclonal antibody to Na+/K+-ATPase (America BioResearch Co.). 

Phrase: "Additional polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "calnexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "(StressGen"

Phrase: ")"

Phrase: "and"

Phrase: "rat Na+/K+-ATPase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "a monoclonal antibody to Na+/K+-ATPase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0313239:K Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0313240:antibody k [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]

Phrase: "(America BioResearch Co."

Phrase: ")."
Processing 00000000.tx.43: Pulse-Chase Experiments-- Confluent CHO and 293cells were incubated in methionine-deficient medium for 1h, followed by pulse labeling with 200Ci/ml [35S]methionine for 20min. 

Phrase: "Pulse-Chase Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "--"

Phrase: "Confluent CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0018555:Chinese Hamster [Mammal]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "293cells"

Phrase: "were"

Phrase: "incubated in methionine-deficient medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0009458:Medium [Intellectual Product]
   760   C0011155:Deficient [Functional Concept]
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0439536:Medium [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1636779:% deficient [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "for 1h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "followed by pulse labeling"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0232117:PULSE [Clinical Attribute]
   770   C0391850:Pulse [Physiologic Function]
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C1947910:Pulse [Phenomenon or Process]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with 200Ci/ml [35S"

Phrase: "]methionine for 20min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.44: The cells were then either lysed immediately or chased in regular medium for 1-8 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "or"

Phrase: "chased in regular medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0205272:Regular [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "for 1-8 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0700308:1 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.45: The cells were then collected and fractionated as described below. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "as"

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.46: Subcellular Fractionation-- Cultured CHO and 293cells were detached from confluent cultures grown in 15-cm dishes with 20mM EDTA in ice-cold phosphate-buffered saline. 

Phrase: "Subcellular Fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "Cultured CHO"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0018555:Chinese Hamster [Mammal]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "293cells"

Phrase: "were"

Phrase: "detached from confluent cultures"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0010453:Cultures [Idea or Concept]
   770   C0205200:Confluent [Qualitative Concept]
   770   C0687118:Detached [Functional Concept]
   770   C1561504:detached [Idea or Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "grown in 15-cm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "with 20mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "in ice-cold phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.47: Cells were pelleted and resuspended in homogenization buffer (10mM HEPES, pH 7.4,1mM EDTA, 0.25M sucrose, supplemented with a protease inhibitor mixture). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in homogenization buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.25M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "supplemented with a protease inhibitor mixture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   790   C3536890:Protease Inhibitor [Pharmacologic Substance]
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0439962:Mixture [Substance]
   753   C1947941:Protease [Enzyme]
   753   C1999216:Inhibitor [Qualitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: ")."
Processing 00000000.tx.48: The cells were disrupted using 10strokes in a Dounce homogenizer followed by four passages through a 25-gauge needle. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10strokes in a Dounce homogenizer"

Phrase: "followed by four passages"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0205450:Four [Quantitative Concept]
   737   C0439799:Passage [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "through a 25-gauge needle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027551:Needle [Medical Device]
   827   C1704318:Needle [Medical Device]
   827   C1882041:Needle [Spatial Concept]
   734   C0456638:25 gauge [Quantitative Concept]
Processing 00000000.tx.49: Nuclei and unbroken cells were pelleted by centrifugation at 3000g for 10min. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "unbroken cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pelleted by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "at 3000g"

Phrase: "for 10min."
Processing 00000000.tx.50: The pellets were resuspended in 1.5ml of homogenization buffer and centrifuged at 3000g for 10min. 

Phrase: "The pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 1.5ml of homogenization buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "centrifuged at 3000g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 10min."
Processing 00000000.tx.51: Postnuclear supernatants from both centrifugation steps were combined and centrifuged at 80,000g for 1h. 

Phrase: "Postnuclear supernatants from both centrifugation steps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "centrifuged at 80,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 1h."
Processing 00000000.tx.52: The vesicle pellet was resuspended in 0.8ml of homogenization buffer. 

Phrase: "The vesicle pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 0.8ml of homogenization buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.53: All operations were carried out at 4C. 

Phrase: "All operations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0038895:operations [Functional Concept]
  1000   C3244305:operations [Functional Concept]
  1000   C3244306:operations [Intellectual Product]
   966 E C0543467:Operation [Health Care Activity]
   966 E C3241922:Operation [Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at 4C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439787:Out [Spatial Concept]
   790   C0450376:4c [Intellectual Product]
   790   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.54: Each cell line was analyzed 2-5 times, and representative experiments are shown under "Results." 

Phrase: "Each cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "2-5 times,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "and"

Phrase: "representative experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "shown under ""Results."""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C1547282:Show [Intellectual Product]
   756   C2825142:Result [Finding]
Processing 00000000.tx.55: The viscosity of the gradient medium is a major determinant of the sedimentation rate. 

Phrase: "The viscosity of the gradient medium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0042784:Viscosity [Natural Phenomenon or Process]
   753   C0391802:viscosity [Laboratory Procedure]
   753   C1547055:*Viscosity [Quantitative Concept]

Phrase: "is"

Phrase: "a major determinant of the sedimentation rate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.56: In addition, because subcellular organelles are osmotically sensitive, the osmotic activity of the gradient medium is particularly important. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "because"

Phrase: "subcellular organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "are"

Phrase: "osmotically sensitive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "the osmotic activity of the gradient medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1518622:Osmotic Activity [Molecular Function]
   778   C3537126:Osmotic Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "particularly important."
Processing 00000000.tx.57: Thus, although sucrose, glycerol, and Ficoll are widely used for gradient fractionation of cellular membranes, they are not ideal in osmolality and viscosity. 

Phrase: "Thus,"

Phrase: "although"

Phrase: "sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ficoll"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016071:Ficoll [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "are"

Phrase: "widely"

Phrase: "used for gradient fractionation of cellular membranes,"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   762   C0007603:Cellular membrane [Cell Component]
   762   C3161472:Cellular Membrane [Cell Component]
   757   C1524063:Use of [Functional Concept]
   748   C0007634:Cellular [Cell]
   748   C0016640:fractionation [Laboratory Procedure]
   748   C0025255:Membranes [Tissue]
   748   C0178539:Cellular [Functional Concept]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0524811:fractionation [Therapeutic or Preventive Procedure]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C0596901:Membrane [Cell Component]
   714 E C1706182:Membrane [Manufactured Object]
   714 E C1947944:Use [Intellectual Product]

Phrase: "they"

Phrase: "are"

Phrase: "not ideal in osmolality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512612:Ideal [Qualitative Concept]

Phrase: "and"

Phrase: "viscosity."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0042784:Viscosity [Natural Phenomenon or Process]
  1000   C0391802:viscosity [Laboratory Procedure]
  1000   C1547055:*Viscosity [Quantitative Concept]
   928 E C0311419:Viscous [Functional Concept]
Processing 00000000.tx.58: OptiPrep (60% (w/v) Life Technologies, Inc.) is a ready made solution of Iodixanol, 5,5'-[(2-hydroxy-1-3-propanediyl)-bis(acetylamino)] bis[N,N'-bis(2,3-dihydroxypropyl-2,4,6-triiodo-1,3-benzenecarboxamide]. 

Phrase: "OptiPrep"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642362:OptiPrep [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(60%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "is"

Phrase: "a ready made solution of Iodixanol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "5'-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "["

Phrase: "(2-hydroxy-1-3-propanediyl"

Phrase: ")-"

Phrase: "bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0556985:BIS [Temporal Concept]
  1000   C2247301:BIS [Molecular Function]
  1000   C3540495:BIS [Intellectual Product]

Phrase: "acetylamino"

Phrase: ")"

Phrase: "] bis[N,N'-bis(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0556985:BIS [Temporal Concept]
   804   C2247301:BIS [Molecular Function]
   804   C3540495:BIS [Intellectual Product]

Phrase: "3-dihydroxypropyl-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "6-triiodo-1,"

Phrase: "3-benzenecarboxamide"

Phrase: "]."
Processing 00000000.tx.59: The advantage of using Iodixanol gradient is that osmolality and viscosity remain relatively constant with changes in the density of the gradient. 

Phrase: "The advantage of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Iodixanol gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "is"

Phrase: "that osmolality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0086741:Osmolality [Clinical Attribute]
  1000   C0201803:Osmolality [Laboratory Procedure]
  1000   C1547034:*Osmolality [Quantitative Concept]
   900 E C0439186:osmol [Quantitative Concept]

Phrase: "and"

Phrase: "viscosity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0042784:Viscosity [Natural Phenomenon or Process]
  1000   C0391802:viscosity [Laboratory Procedure]
  1000   C1547055:*Viscosity [Quantitative Concept]
   928 E C0311419:Viscous [Functional Concept]

Phrase: "remain"

Phrase: "relatively constant with changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1547014:*Constant [Quantitative Concept]
   770   C1948059:Constant [Qualitative Concept]

Phrase: "in the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of the gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.60: Under this mild iso-osmotic condition, all organelles and endosomes can be isolated intact, without loss of water as the density of the gradient increases. 

Phrase: "Under this mild iso-osmotic condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]

Phrase: "all organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]

Phrase: "and"

Phrase: "endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "can"

Phrase: "be"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "without loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "as the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of the gradient increases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1880999:GRADIENT INCREASE [Event]
   861   C0442805:increases [Functional Concept]
Processing 00000000.tx.61: A gradient stock solution of 50% Iodixanol was prepared by diluting in 0.25M sucrose, 6 mM EDTA, 60mM HEPES, pH 7.4,at a 5:1 ratio. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A gradient stock solution of 50% Iodixanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "prepared by diluting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1521827:Prepare [Functional Concept]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "in 0.25M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "6 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "60mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "at a 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "1 ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.62: Linear gradients of 1-20% Iodixanol were formed using a gradient maker. 

Phrase: "Linear gradients of 1-20% Iodixanol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0812409:gradients [Quantitative Concept]
   719 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a gradient maker."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0554244:Maker [Professional or Occupational Group]
   861   C0947322:Maker [Intellectual Product]
Processing 00000000.tx.63: The resuspended vesicle preparations were loaded on top of the gradient and centrifuged in a Beckman SW41 rotor at 200,000g for 3h at 4C. 

Phrase: "The resuspended vesicle preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "loaded on top of the gradient"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1704458:Top [Spatial Concept]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "centrifuged in a Beckman SW41 rotor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0179834:centrifuge [Medical Device]

Phrase: "at 200,"

Phrase: "000g for 3h"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.64: Sequential 1-ml fractions were then collected from the bottom of the gradient. 

Phrase: "Sequential 1-ml fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected from the bottom of the gradient."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1511276:Bottom [Spatial Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1552825:bottom [Idea or Concept]
Processing 00000000.tx.65: The subcellular markers, calnexin, galactosyltransferase, and Na+/K+-ATPase, were analyzed in each gradient preparation. 

Phrase: "The subcellular markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "calnexin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "galactosyltransferase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Na+/K+-ATPase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "analyzed in each gradient preparation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0455052:Preparation [Health Care Activity]
   760   C0812409:Gradient [Quantitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.66: Immunoprecipitation and Western Blotting-- Subcellular fractions collected from linear Iodixanol gradients were lysed by addition of Nonidet P-40 to a final concentration of 1%. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Subcellular fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0038528:Subcellular Fractions [Cell Component]
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "collected from linear Iodixanol gradients"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0063757:iodixanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0205132:Linear [Spatial Concept]
   760   C0812409:gradients [Quantitative Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "lysed by addition of Nonidet P-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   748   C0024348:lysed [Pathologic Function]
   748   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   748   C0439509:/40 [Temporal Concept]
   748   C1883712:Addition [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.67: Immunoprecipitations from whole cell lysates or Iodixanol gradient fractions were performed as described previously (10). 

Phrase: "Immunoprecipitations from whole cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "or"

Phrase: "Iodixanol gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.68: Resultant immunoprecipitates were resuspended in Laemmli sample buffer, separated in 8-16% SDS-polyacrylamide gel electrophoresis, and transferred to either polyvinylidene difluoride or supported nitrocellulose membranes. 

Phrase: "Resultant immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "resuspended in Laemmli sample buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "separated in 8-16% SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   800   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred to either polyvinylidene difluoride"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "or"

Phrase: "supported nitrocellulose membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.69: Samples from pulse-chase experiments were transferred to membranes following fractionation and quantitated directly by phosphor imaging. 

Phrase: "Samples from pulse-chase experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "transferred to membranes"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0025255:Membranes [Tissue]
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C0596901:Membrane [Cell Component]
   756 E C1705822:Transfer [Activity]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "quantitated"

Phrase: "directly by phosphor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0259980:phosphor [Chemical Viewed Functionally]
   790   C1947931:Directly [Qualitative Concept]
   718 E C0031705:Phosphoric [Element, Ion, or Isotope]

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.70: Western blotting was carried out with antibodies as indicated for each experiment. 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated for each experiment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1444656:Indicated [Finding]
   770   C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.71: Primary antibodies were visualized with either 125I-conjugated secondary antibody or with peroxidase-conjugated secondary antibody and detected with Super-Signal enhanced chemiluminescence (Pierce). 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "visualized with either 125I-conjugated secondary antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0234621:Visualized [Functional Concept]
   748   C0522529:Conjugated [Spatial Concept]

Phrase: "or with peroxidase-conjugated secondary antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0027627:secondary [Neoplastic Process]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "detected with Super-Signal enhanced chemiluminescence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   753   C0442726:Detected [Finding]
   753   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1710082:Signal [Phenomenon or Process]
   753   C2349975:Enhanced [Activity]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.72: The signals were quantitated by phosphor imaging or densitometry, respectively. 

Phrase: "The signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantitated by phosphor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0259980:phosphor [Chemical Viewed Functionally]
   718 E C0031705:Phosphoric [Element, Ion, or Isotope]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "or"

Phrase: "densitometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "respectively."
Processing 00000000.tx.73: Galactosyltransferase Assay-- -1,4-Galactosyltransferase assay was performed from the Iodixanol fractions according to the method of Bretz and Staubli (20), in which the addition of [3H]galactose onto the oligosaccharides of an acceptor protein, ovomucoid, was measured.  

Phrase: "Galactosyltransferase Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "-- -"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-Galactosyltransferase assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed from the Iodixanol fractions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0063757:iodixanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0884358:Performed [Functional Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Bretz"

Phrase: "and"

Phrase: "Staubli"

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the addition of [3H]galactose onto the oligosaccharides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0016945:Galactose [Biologically Active Substance,Carbohydrate]
   744   C1442460:3H [Temporal Concept]

Phrase: "of an acceptor protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ovomucoid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029960:Ovomucoid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.74: RESULTS Top Abstract Introduction Materials & Methods Results Discussion References Subcellular Fractionation by Iodixanol Gradient-- CHO cells, stably transfected with PS1 (WT, M146L, or C410Y) or PS2 (WT or N141I), and 293cells, stably transfected with PS1 (WT or E9), under the ecdysone-inducible system were analyzed by subcellular fractionation. 

Phrase: "RESULTS Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subcellular Fractionation by Iodixanol Gradient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1656251:subcellular fractionation [Laboratory Procedure]
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "--"

Phrase: "CHO cells,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "stably"

Phrase: "transfected with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(WT, M146L,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "C410Y"

Phrase: ")"

Phrase: "or"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "N141I"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "293cells,"

Phrase: "stably"

Phrase: "transfected with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "E9"

Phrase: ")"

Phrase: ","

Phrase: "under the ecdysone-inducible system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "were"

Phrase: "analyzed by subcellular fractionation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1656251:subcellular fractionation [Laboratory Procedure]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.75: Subcellular vesicles were separated on 1-20% continuous Iodixanol gradients as described under "Materials and Methods." 

Phrase: "Subcellular vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "separated on 1-20% continuous Iodixanol gradients"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0063757:iodixanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0549178:Continuous [Idea or Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0812409:gradients [Quantitative Concept]
   714 E C0439182:% gradient [Quantitative Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.76: ER-rich fractions were found, as expected, at the bottom of the gradient, using an antibody against the well characterized ER marker protein, calnexin (21) (Fig. 1, A and B). 

Phrase: "ER-rich fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "at the bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "of the gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody against the well characterized ER marker protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "calnexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]

Phrase: "(21"

Phrase: ")"

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.77: Calnexin-reactive ER vesicles were most enriched in fractions 1-4. 

Phrase: "Calnexin-reactive ER vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   867   C0026029:Endoplasmic reticulum vesicle [Cell Component]
   804   C0333262:VESICLES [Acquired Abnormality]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "enriched in fractions 1-4."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0359583:enriched [Food]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.78: Golgi-containing fractions were identified by assaying for -1,4-galactosyltransferase, a trans-Golgi enzyme (20), and this was principally found in fractions 4-7 (Fig. 1, A and B). 

Phrase: "Golgi-containing fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "identified by assaying"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "for -1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-galactosyltransferase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a trans-Golgi enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "was"

Phrase: "principally"

Phrase: "found in fractions 4-7"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0150312:Found [Quantitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C0243095:Find [Finding]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.79: Immunoreactivity against Na+/K+-ATPase, a marker for plasma membrane, was found on the top of the gradient, i.e. fractions 9-12, although lesser amounts of immunoreactivity were also present in the mid-density region (fractions 5-8) (not shown). 

Phrase: "Immunoreactivity against Na+/K+-ATPase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "a marker for plasma membrane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "was"

Phrase: "found on the top of the gradient,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0150312:Found [Quantitative Concept]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1704458:Top [Spatial Concept]
   714 E C0243095:Find [Finding]

Phrase: "i.e. fractions 9-12,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "although"

Phrase: "lesser amounts of immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "present in the mid-density region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0150312:Present [Quantitative Concept]
   753   C0178587:density [Quantitative Concept]
   753   C0205147:Region [Spatial Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "(fractions 5-8"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: The latter reactivity was derived from molecules transiting the Golgi. 

Phrase: "The latter reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "was"

Phrase: "derived from molecules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0567416:molecules [Substance]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]
   706 E C1521991:Molecular [Qualitative Concept]

Phrase: "transiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1301827:transit [Functional Concept]

Phrase: "the Golgi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]
Processing 00000000.tx.81: As an additional marker, CHO cells stably expressing WT APP751 were fractionated and analyzed by blotting with antibody CT15 (to the C terminus of APP). 

Phrase: "As an additional marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "CHO cells stably"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   904   C0085080:Chinese Hamster Ovary Cell [Cell]
   840   C0018555:Chinese Hamster [Mammal]
   804   C0007634:Cells [Cell]
   804   C0008120:chinese [Language]
   804   C0018557:Hamster [Mammal]
   804   C0029939:Ovary [Body Part, Organ, or Organ Component]
   804   C0152035:Chinese [Population Group]
   804   C0227898:ovary [Body Part, Organ, or Organ Component]
   804   C1278992:Ovary [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "WT APP751"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "analyzed by blotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "with antibody CT15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412189:CT15 [Gene or Genome]

Phrase: "("

Phrase: "to the C terminus"

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.82: As expected, the immature (primarily N-glycosylated) forms of APP appeared in the ER-rich fractions (fractions 1-4) (Fig. 1C), whereas the mature (N- plus O-glycosylated) forms of APP appeared only in Golgi-rich fractions 4-7. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the immature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205252:Immature [Temporal Concept]

Phrase: "(primarily N-glycosylated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   755   C0017982:Glycosylations [Natural Phenomenon or Process]
   755   C0376322:Glycosylation [Molecular Function]

Phrase: ")"

Phrase: "forms of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1522492:Form [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "appeared in the ER-rich fractions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0699759:Rich [Qualitative Concept]
   748   C1264633:Fractions [Quantitative Concept]
   714   C0700364:APPEAR [Qualitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "(fractions 1-4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the mature"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205286:Mature [Temporal Concept]
   928 E C0449989:Maturity [Qualitative Concept]
   928 E C0700597:Maturity [Temporal Concept]

Phrase: "(N- plus O-glycosylated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0017982:Glycosylations [Natural Phenomenon or Process]
   741   C0376322:Glycosylation [Molecular Function]

Phrase: ")"

Phrase: "forms of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1522492:Form [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "only in Golgi-rich fractions 4-7."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0018042:Golgi [Cell Component]
   748   C0205171:Only [Quantitative Concept]
   748   C0699759:Rich [Qualitative Concept]
   748   C1264633:Fractions [Quantitative Concept]
   748   C1720467:Only [Intellectual Product]
   714 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.83: These data indicate that ER and Golgi plasma membrane fractions are effectively separated on these 1-20% Iodixanol gradients. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi plasma membrane fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]
   708   C0230764:Golgi membrane [Cell Component]

Phrase: "are"

Phrase: "effectively"

Phrase: "separated on these 1-20% Iodixanol gradients."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0063757:iodixanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0812409:gradients [Quantitative Concept]
   714 E C0439182:% gradient [Quantitative Concept]
Processing 00000000.tx.84: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.85: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.86: Distribution of major subcellular markers and APP in continuous 1-20% Iodixanol gradients. 

Phrase: "Distribution of major subcellular markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "APP in continuous 1-20% Iodixanol gradients."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.87: Representative results from subcellular fractionation of CHO cells (A) and 293cells (B) are shown. 

Phrase: "Representative results from subcellular fractionation of CHO cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "(A"

Phrase: "A"

Phrase: ")"

Phrase: "and"

Phrase: "293cells"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.88: Distribution of calnexin was determined by immunoblotting. 

Phrase: "Distribution of calnexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "determined by immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.89: Distribution of -1,4-galactosyltransferase was determined by enzyme activity assay. 

Phrase: "Distribution of -1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "4-galactosyltransferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined by enzyme activity assay."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0243102:enzyme activity [Molecular Function]
   797   C2717977:Enzyme Assay [Laboratory Procedure]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205177:Activity [Functional Concept]
   760   C0243073:assay [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1510438:Assay [Laboratory Procedure]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.90: The results are expressed as percentages of the respective signals in each fraction to the sum of all fractions. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as percentages of the respective signals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0439165:Percentage [Quantitative Concept]
   714   C1549488:Percentage [Idea or Concept]
   714   C1561533:Percentage [Idea or Concept]
   714   C1710082:Signal [Phenomenon or Process]

Phrase: "in each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "to the sum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515051:Sum [Quantitative Concept]

Phrase: "of all fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.91: The ER marker calnexin was primarily located in fractions 1-4, and Golgi marker galactosyltransferase was distributed mainly in fractions 4-8. 

Phrase: "The ER marker calnexin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1413107:CALNEXIN [Gene or Genome]

Phrase: "was"

Phrase: "primarily"

Phrase: "located in fractions 1-4,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "Golgi marker galactosyltransferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "mainly in fractions 4-8."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.92: In C, the subcellular distribution of APP was determined from CHO cells stably transfected with APP751. 

Phrase: "In C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "the subcellular distribution of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0872250:protein distribution [Cell Function]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "determined from CHO cells stably"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   840   C0085080:cells chinese hamster ovary [Cell]
   778   C0018555:Chinese Hamster [Mammal]
   748   C0007634:Cells [Cell]
   748   C0008120:chinese [Language]
   748   C0018557:Hamster [Mammal]
   748   C0029939:Ovary [Body Part, Organ, or Organ Component]
   748   C0152035:Chinese [Population Group]
   748   C0227898:ovary [Body Part, Organ, or Organ Component]
   748   C1278992:Ovary [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP751."
Processing 00000000.tx.93: Following fractionation and SDS-polyacrylamide gel electrophoresis, the samples were immunoblotted with an APP C-terminal antibody, CT15. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "SDS-polyacrylamide gel electrophoresis,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immunoblotted with an APP C-terminal antibody,"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1168438:Protein C [Laboratory Procedure]
   764   C1418943:PROTEIN C [Gene or Genome]
   764   C1707271:C-Terminal [Amino Acid Sequence]
   764   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1709634:Precursor [Idea or Concept]
   708   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "CT15."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412189:CT15 [Gene or Genome]
Processing 00000000.tx.94: The immature APP isoforms were present in the ER-rich fractions 1-4, whereas the mature forms of APP appeared primarily in Golgi-rich fractions 4-7. 

Phrase: "The immature APP isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "were"

Phrase: "present in the ER-rich fractions 1-4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "whereas"

Phrase: "the mature forms of APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "primarily in Golgi-rich fractions 4-7."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0018042:Golgi [Cell Component]
   748   C0699759:Rich [Qualitative Concept]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.95: Subcellular Distribution of PS1 and PS2-- To determine the distribution of PS1, we performed Western blot analysis of the gradient fractions from PS1 stably transfected CHO cells. 

Phrase: "Subcellular Distribution of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the distribution of PS1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Western blot analysis of the gradient fractions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "from PS1 stably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "transfected"

Phrase: "CHO cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.96: Antibody J27 raised to the N terminus of PS1 recognized a ~45-kDa PS1 holoprotein derived from the transgene mainly in gradient fractions 1-4, where it co-localized with the ER marker calnexin (Fig. 2, A and B). 

Phrase: "Antibody J27"

Phrase: "raised to the N terminus of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0442818:Raised [Quantitative Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "recognized"

Phrase: "a ~45-kDa PS1 holoprotein"

Phrase: "derived from the transgene mainly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0282641:Transgene [Gene or Genome]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "in gradient fractions 1-4,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0439182:% gradient [Quantitative Concept]
   812   C0812409:Gradient [Quantitative Concept]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "where"

Phrase: "it"

Phrase: "co-localized with the ER marker calnexin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   744   C0005516:Marker [Clinical Attribute]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392752:Localized [Spatial Concept]
   744   C1413107:CALNEXIN [Gene or Genome]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.97: In contrast, the major N-terminal endoproteolytic fragment (~29 kDa) was consistently localized to the lighter fractions toward the middle of the gradient, principally in fractions 4-7 (Fig. 2, A and B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the major N-terminal endoproteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "(~29 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "consistently"

Phrase: "localized to the lighter fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0336769:Lighter [Manufactured Object]
   760   C0392752:Localized [Spatial Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "toward the middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: "of the gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "principally in fractions 4-7"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.98: Similarly, the major C-terminal fragment (~18 kDa) was distributed in fractions 3-8 (Fig. 2, C and D). 

Phrase: "Similarly,"

Phrase: "the major C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(~18 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "distributed in fractions 3-8"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1264633:Fractions [Quantitative Concept]
   760   C1704711:Distributed [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.99: Both PS1 NTF and CTF colocalized with the Golgi marker, -1,4-galactosyl-transferase. 

Phrase: "Both PS1 NTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "colocalized with the Golgi marker, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005516:Marker [Clinical Attribute]
   760   C0018042:Golgi [Cell Component]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-galactosyl-transferase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.100: Fractionation of stable transfectants expressing the PS1 missense mutations M146L or C410Y showed no significant differences from WT PS1 in subcellular distribution of the holoprotein and its N- and C-terminal fragments (not shown). 

Phrase: "Fractionation of stable transfectants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "expressing"

Phrase: "the PS1 missense mutations M146L"

Phrase: "or"

Phrase: "C410Y"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no significant differences from WT PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "in subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "of the holoprotein"

Phrase: "and"

Phrase: "its N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.103: Subcellular distribution of PS1 in stably transfected CHO cells. 

Phrase: "Subcellular distribution of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in stably"

Phrase: "transfected"

Phrase: "CHO cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.104: In this representative experiment, the fractions were immunoblotted with either the N-terminal antibody, J27 (A and B), or with the C-terminal antibody, 4627(C and D). 

Phrase: "In this representative experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "immunoblotted with either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "the N-terminal antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "J27"

Phrase: "(A"

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or with the C-terminal antibody,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   783   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "4627"

Phrase: "(C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.105: The signal from full-length PS1, NTF, and CTF in each fraction was expressed as a percentage of the sum of all of the fractions (B and D). 

Phrase: "The signal from full-length PS1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF in each fraction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "expressed as a percentage of the sum of all of the fractions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   736   C0439165:Percentage [Quantitative Concept]
   736   C1264633:Fractions [Quantitative Concept]
           Fraction of
   736   C1515051:Sum [Quantitative Concept]
   736   C1549488:Percentage [Idea or Concept]
   736   C1561533:Percentage [Idea or Concept]
   703 E C1554103:Fraction [Idea or Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.106: PS1 holoprotein was found mainly in gradient fractions 1-4, co-localized with the ER marker calnexin. 

Phrase: "PS1 holoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "mainly in gradient fractions 1-4,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "co-localized with the ER marker calnexin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   744   C0005516:Marker [Clinical Attribute]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392752:Localized [Spatial Concept]
   744   C1413107:CALNEXIN [Gene or Genome]
Processing 00000000.tx.107: The ~29-kDa major NTF was located principally in fractions 4-7. 

Phrase: "The ~29-kDa major NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "located"

Phrase: "principally in fractions 4-7."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.108: Similarly, the ~18-kDa major CTF was distributed in fractions 3-8. 

Phrase: "Similarly,"

Phrase: "the ~18-kDa major CTF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "distributed in fractions 3-8."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1264633:Fractions [Quantitative Concept]
   760   C1704711:Distributed [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.109: Both NTF and CTF colocalized with the Golgi marker -1,4-galactosyltransferase in the respective experiments. 

Phrase: "Both NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "colocalized with the Golgi marker -1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005516:Marker [Clinical Attribute]
   753   C0018042:Golgi [Cell Component]

Phrase: "4-galactosyltransferase in the respective experiments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016964:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0702242:Galactosyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.110: We next examined CHO cells stably transfected with PS2 cDNA using the same gradient fractionation and blotting with a PS2 N-terminal antibody (antibody 1209). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "CHO cells stably"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   904   C0085080:Chinese Hamster Ovary Cell [Cell]
   840   C0018555:Chinese Hamster [Mammal]
   804   C0007634:Cells [Cell]
   804   C0008120:chinese [Language]
   804   C0018557:Hamster [Mammal]
   804   C0029939:Ovary [Body Part, Organ, or Organ Component]
   804   C0152035:Chinese [Population Group]
   804   C0227898:ovary [Body Part, Organ, or Organ Component]
   804   C1278992:Ovary [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS2 cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418986:PRESENILIN 2 [Gene or Genome]
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same gradient fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "blotting with a PS2 N-terminal antibody"

Phrase: "(antibody 1209"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.111: Full-length PS2 molecules were detected as a characteristic ~50-kDa band principally in ER-rich fractions 3and 4(Fig. 

Phrase: "Full-length PS2 molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0567416:molecules [Substance]
   721 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "detected as a characteristic ~50-kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1521970:Characteristic [Qualitative Concept]
   753   C1532717:kDa [Quantitative Concept]

Phrase: "band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "principally in ER-rich fractions 3and 4"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0699759:Rich [Qualitative Concept]
   744   C1264633:Fractions [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 3, A and B), whereas the N-terminal fragment was localized primarily in Golgi-rich fractions 5-8. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the N-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "primarily in Golgi-rich fractions 5-8."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0018042:Golgi [Cell Component]
   748   C0699759:Rich [Qualitative Concept]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.113: Moreover, as seen above with PS1 mutations, the distribution of the N141I mutant form of PS2 was identical to that of WT PS2 (data not shown). 

Phrase: "Moreover,"

Phrase: "as"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "above with PS1 mutations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1282910:Above [Spatial Concept]
   760   C1552828:above [Idea or Concept]

Phrase: "the distribution of the N141I mutant form of PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0520511:distribution [Idea or Concept]
   739   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "identical to that of WT PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: Therefore, the subcellular distribution of PS2 and its proteolytic fragment was very similar to that obtained for PS1 and its fragments. 

Phrase: "Therefore,"

Phrase: "the subcellular distribution of PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "its proteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "very similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "obtained for PS1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "its fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.115: View larger version (43K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.116: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.117: Subcellular distribution of PS2. 

Phrase: "Subcellular distribution of PS2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.118: CHO cells expressing WT PS2 were fractionated on Iodixanol gradients as before and immunoblotted with the PS2 N-terminal antibody, 1509(A). 

Phrase: "CHO cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "WT PS2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0441730:Type 2 [Classification]
   861   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418986:PRESENILIN 2 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "fractionated on Iodixanol gradients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0063757:iodixanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0812409:gradients [Quantitative Concept]
   770   C1979893:Fractionated [Qualitative Concept]
   737 E C0439182:% gradient [Quantitative Concept]

Phrase: "as"

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotted with the PS2 N-terminal antibody,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418986:PRESENILIN 2 [Gene or Genome]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205088:Terminal [Temporal Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   711   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "1509"

Phrase: "(A"

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.119: The signal from full-length PS2 and NTF in each fraction was expressed as a percentage of the sum of all the fractions (B). 

Phrase: "The signal from full-length PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "NTF in each fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "expressed as a percentage of the sum of all"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439165:Percentage [Quantitative Concept]
   742   C1515051:Sum [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]

Phrase: "the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.120: Similar to PS1, the ~50-kDa full-length PS2 molecules were found principally in ER fractions 3-5, whereas the ~33-kDa major NTF was localized primarily in Golgi fractions 5-8. 

Phrase: "Similar to PS1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "the ~50-kDa full-length PS2 molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0567416:molecules [Substance]
   712 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "principally in ER fractions 3-5,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "whereas"

Phrase: "the ~33-kDa major NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "primarily in Golgi fractions 5-8."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0018042:Golgi [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.121: 293 cells expressing WT PS1 showed a pattern of distribution of holoprotein and stable fragments very similar to that seen in the CHO-transfected cells, although there was a tendency for the Golgi fractions to be distributed over a larger number of lighter fractions. 

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "WT PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0441729:Type 1 [Classification]
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a pattern of distribution of holoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0449775:Distribution pattern [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "stable fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "very similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "seen in the CHO-transfected cells,"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   822   C0085080:cells chinese hamster ovary [Cell]
   770   C0018555:Chinese Hamster [Mammal]
   744   C0007634:Cells [Cell]
   744   C0008120:chinese [Language]
   744   C0018557:Hamster [Mammal]
   744   C0029939:Ovary [Body Part, Organ, or Organ Component]
   744   C0152035:Chinese [Population Group]
   744   C0205397:Seen [Qualitative Concept]
   744   C0227898:ovary [Body Part, Organ, or Organ Component]
   744   C1278992:Ovary [Body Part, Organ, or Organ Component]
   744   C3282337:Cells [Cell]
   711 E C0042789:see [Organism Function]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1947903:See [Activity]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "there"

Phrase: "was"

Phrase: "a tendency for the Golgi fractions to"

Phrase: "be"

Phrase: "distributed over a larger number of lighter fractions."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   793   C0454266:Number of fractions [Quantitative Concept]
   750   C1264633:Fraction of [Quantitative Concept]
           Fractions
   750   C1264664:*Number Fraction [Quantitative Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0336769:Lighter [Manufactured Object]
   744   C0443228:larger [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0549177:Larger [Quantitative Concept]
   744   C1704243:Larger [Quantitative Concept]
   744   C1704711:Distributed [Functional Concept]
   711 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.122: However, E9 mutant protein, which does not undergo the conventional endoproteolytic cleavage (12), was widely distributed throughout the gradient fractions (Fig. 4, A and B). 

Phrase: "However,"

Phrase: "E9 mutant protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "the conventional endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "widely"

Phrase: "distributed throughout the gradient fractions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1704711:Distributed [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.123: The extension of E9 PS1 into the lighter Golgi fractions was not a result of overexpression, because the same result was seen when muristerone A was reduced in this cell line to match the level of expression seen in WT PS1-transfected 293cells (Fig. 4, A and B). 

Phrase: "The extension of E9 PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231448:Extension [Functional Concept]
   753   C1880641:Extension [Conceptual Entity]

Phrase: "into the lighter Golgi fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a result of overexpression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "because"

Phrase: "the same result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "muristerone A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "was"

Phrase: "reduced in this cell line to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "match"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:match [Research Activity]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "the level of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C3244092:expression level [Idea or Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "seen in WT PS1-transfected 293cells"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C1883559:Wild Type [Organism Attribute]
   767   C0441729:Type 1 [Classification]
   744   C0205397:Seen [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.124: As expected, we observed no conventional proteolytic fragments from E9 PS1 protein. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no conventional proteolytic fragments from E9 PS1 protein."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   745   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   708 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.125: Furthermore, as reported (22), the level of N-terminal fragment derived from endogenous PS1 decreased as the E9 PS1 expression increased with higher muristerone A induction (Fig. 4A). 

Phrase: "Furthermore,"

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "the level of N-terminal fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "derived from endogenous PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0205227:Endogenous [Functional Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "decreased as the E9 PS1 expression"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "increased with higher muristerone A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0208785:muristerone [Steroid]
   760   C0442805:Increased [Functional Concept]
   756   C0557899:Height increased [Finding]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "A induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.126: The distribution of the NTF in the WT PS1 and E9-transfected cell lines, the latter with or without induction, was identical; 

Phrase: "The distribution of the NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in the WT PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0441729:Type 1 [Classification]
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "E9-transfected cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "the latter with"

Phrase: "or without induction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "identical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.127: in the case of the latter cells, the NTF was derived only from endogenous PS1. 

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of the latter cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "only from endogenous PS1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0205171:Only [Quantitative Concept]
   760   C0205227:Endogenous [Functional Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1720467:Only [Intellectual Product]
Processing 00000000.tx.128: Therefore, the subcellular distribution of transgene-derived PS1 fragments was not altered by the transfection or overexpression. 

Phrase: "Therefore,"

Phrase: "the subcellular distribution of transgene-derived PS1 fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by the transfection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]
Processing 00000000.tx.129: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.130: 4.  

Phrase: "4."
Processing 00000000.tx.131: Subcellular distribution of WT and E9 mutant PS1. 

Phrase: "Subcellular distribution of WT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "E9 mutant PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.132: 293cells stably expressing WT and E9 PS1 were induced overnight with 0-1 M muristerone A, followed by Iodixanol fractionation and immunoblotting with PS1 N-terminal monoclonal antibody, PSN2 (A). 

Phrase: "293cells stably"

Phrase: "expressing"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "E9 PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "overnight with 0-1 M muristerone A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0369637:M not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           M NOS
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0208785:muristerone [Steroid]
   748   C0439583:Overnight [Temporal Concept]
   748   C0441923:M+ [Intellectual Product]

Phrase: "A,"

Phrase: "followed by Iodixanol fractionation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0063757:iodixanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting with PS1 N-terminal monoclonal antibody,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "PSN2"

Phrase: "(A"

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.133: The cells were induced with the amount of muristerone A indicated on the left. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced with the amount of muristerone A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0208785:muristerone [Steroid]
   748   C1265611:Amount [Quantitative Concept]

Phrase: "A"

Phrase: "indicated on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.134: The signals from WT and E9 PS1 cells induced with 1M and 0.125M muristerone A, respectively, were quantitated from each fraction and expressed as a percentage of the total signal. 

Phrase: "The signals from WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "E9 PS1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "induced with 1M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0470296:1M [Quantitative Concept]

Phrase: "and"

Phrase: "0.125M muristerone A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A,"

Phrase: "respectively,"

Phrase: "were"

Phrase: "quantitated from each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "expressed as a percentage of the total signal."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0439165:Percentage [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.135: Mutant E9 holoprotein, in contrast to WT PS1, extended from ER to Golgi fractions. 

Phrase: "Mutant E9 holoprotein,"

Phrase: "in contrast to WT PS1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0441729:Type 1 [Classification]
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "extended from ER"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]

Phrase: "to Golgi fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.136: Note that the levels of NTF derived from endogenous PS1 decreased as E9 expression increased with higher muristerone A induction. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the levels of NTF"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "derived from endogenous PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0205227:Endogenous [Functional Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "decreased as E9 expression"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "increased with higher muristerone A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0208785:muristerone [Steroid]
   760   C0442805:Increased [Functional Concept]
   756   C0557899:Height increased [Finding]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "A induction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.137: E9 Mutant PS1 Has a Longer Half-life-- It has been reported that transfected full-length presenilin, mainly located in ER as shown above, has a short half-life, while N- and C-terminal fragments, mainly located in Golgi as shown above, have a substantially longer half-life (9, 22). 

Phrase: "E9 Mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Has"

Phrase: "a Longer Half-life"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0018517:Half-Life [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   827   C2825407:Half [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "-"

Phrase: "-"

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that transfected full-length presenilin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mainly"

Phrase: "located in ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "shown above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "has"

Phrase: "a short half-life,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0018517:Half-Life [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   827   C2825407:Half [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "while"

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal fragments,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "mainly"

Phrase: "located in Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018042:Golgi [Cell Component]

Phrase: "as"

Phrase: "shown above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "have"

Phrase: "a substantially longer half-life"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018517:Half-Life [Temporal Concept]
   812   C0376558:Life [Idea or Concept]
   812   C2825407:Half [Quantitative Concept]
   729 E C0595998:lives [Finding]

Phrase: "(9,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.138: Futhermore, our results showed that E9 protein, extending from ER to Golgi-rich and lighter fractions, had a distinctly different subcellular distribution as compared with WT PS1 holoprotein. 

Phrase: "Futhermore,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that E9 protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extending from ER"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   770   C0439792:Extending [Spatial Concept]
   737 E C0231448:Extend [Functional Concept]

Phrase: "to Golgi-rich"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699759:Rich [Qualitative Concept]

Phrase: "and"

Phrase: "lighter fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "had"

Phrase: "a distinctly different subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520511:distribution [Idea or Concept]
   812   C1704711:Distribution [Functional Concept]

Phrase: "as"

Phrase: "compared with WT PS1 holoprotein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0441729:Type 1 [Classification]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.139: To determine whether the E9 mutant has a different turnover rate, WT and E9 PS1 stably transfected 293cells were pulse-labeled for 20min and chased for 0,1,2,4,or 8h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the E9 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "a different turnover rate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "E9 PS1 stably transfected 293cells"

Phrase: "were"

Phrase: "pulse-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "labeled for 20min"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "chased for 0,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "or"

Phrase: "8h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292429:8H [Temporal Concept]
Processing 00000000.tx.140: The half-life of WT PS1 was under 1h (average of approximately 50min from multiple experiments) for the holoprotein and more than 8h for the NTF (Fig. 5, A and B). 

Phrase: "The half-life of WT PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018517:Half-Life [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C2825407:Half [Quantitative Concept]

Phrase: "was under 1h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
   790   C1442450:1H [Temporal Concept]

Phrase: "(average of approximately 50min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1510992:Average [Quantitative Concept]
   770   C2825518:AVERAGE [Quantitative Concept]

Phrase: "from multiple experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: ")"

Phrase: "for the holoprotein"

Phrase: "and"

Phrase: "more than 8h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205172:More [Functional Concept]
   790   C1292429:8H [Temporal Concept]

Phrase: "for the NTF (Fig. 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: On the other hand, the half-life of E9 was consistently twice as long as WT PS1 holoprotein (Fig. 5, A and B). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the half-life of E9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0018517:Half-Life [Temporal Concept]
   760   C0376558:Life [Idea or Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "consistently twice as long"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205166:Long [Qualitative Concept]
   770   C1706317:Long [Qualitative Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "as WT PS1 holoprotein"

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.142: At steady state conditions as documented in the experiments described above, E9 protein was also present in the Golgi fractions, where stable proteolytic fragments derived from endogenous PS1 were located. 

Phrase: "At steady state conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C0678587:steady state [Natural Phenomenon or Process]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as"

Phrase: "documented in the experiments"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiments [Research Activity]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above, E9 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "present in the Golgi fractions,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0018042:Golgi [Cell Component]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "where stable proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from endogenous PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0205227:Endogenous [Functional Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "located."
Processing 00000000.tx.143: Surprisingly, the distribution of the E9 mutant PS1 was not substantially altered during the chase period (Fig. 5C). 

Phrase: "Surprisingly,"

Phrase: "the distribution of the E9 mutant PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "not substantially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered during the chase period"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Altered [Functional Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1948053:Period [Temporal Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.144: After 4h, the profile of E9 protein was similar to that seen at earlier time points, i.e. predominantly in ER fractions, whereas there was virtually no labeled PS1 WT holoprotein remaining in the cell (Fig. 5C). 

Phrase: "After 4h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "the profile of E9 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen at earlier time points,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C0042789:see [Organism Function]
   726   C1279919:Early [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726 E C1947903:See [Activity]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "i.e. predominantly in ER fractions,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   778   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   748   C0021966:I- [Inorganic Chemical]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "whereas"

Phrase: "there"

Phrase: "was"

Phrase: "virtually"

Phrase: "no labeled PS1 WT holoprotein remaining in the cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1527428:Remaining [Qualitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.145: Therefore, diminished degradation within the ER appears to account in large part for the prolonged half-life of E9 rather than a shift of the proteins into the Golgi fractions, where the turnover rate may be slowed. 

Phrase: "Therefore,"

Phrase: "diminished degradation within the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account in large part"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0449719:Part [Spatial Concept]
   770   C0549177:Large [Quantitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C1709471:Part [Quantitative Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "for the prolonged half-life"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0018517:Half-Life [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   827   C2825407:Half [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "of E9"

Phrase: "rather than"

Phrase: "a shift of the proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333051:Shift [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]

Phrase: "into the Golgi fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "where"

Phrase: "the turnover rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "slowed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]
Processing 00000000.tx.146: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.148: Half-life of WT and E9 mutant PS1. 

Phrase: "Half-life of WT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0018517:Half-Life [Temporal Concept]
   760   C0376558:Life [Idea or Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "E9 mutant PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.149: After overnight induction with 1M (WT PS1) and 0.125M (E9) muristerone A, the cells were pulse-labeled and chased for 0-8 h. 

Phrase: "After overnight induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "with 1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "(WT PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0441729:Type 1 [Classification]
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "and"

Phrase: "0.125M"

Phrase: "(E9"

Phrase: ")"

Phrase: "muristerone A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pulse-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "chased for 0-8 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.150: An aliquot of cells at each time point was lysed and immunoprecipitated with the N-terminal antibody, J27 (A). 

Phrase: "An aliquot of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510844:Aliquot [Quantitative Concept]

Phrase: "at each time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "immunoprecipitated with the N-terminal antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "J27 (A)."
Processing 00000000.tx.151: The signal at each time point of the chase period shown in A was quantitated and expressed as a percentage of time 0(B). 

Phrase: "The signal at each time point of the chase period"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1710082:Signal [Phenomenon or Process]

Phrase: "shown in A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C1547282:Show [Intellectual Product]

Phrase: "A"

Phrase: "was"

Phrase: "quantitated"

Phrase: "and"

Phrase: "expressed as a percentage of time 0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0040223:Time [Temporal Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: In this experiment, the half-life of WT PS1 and E9 was 40and 80min, respectively. 

Phrase: "In this experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the half-life of WT PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018517:Half-Life [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "E9"

Phrase: "was"

Phrase: "40and 80min,"

Phrase: "respectively."
Processing 00000000.tx.153: In C, immunoprecipitation with J27 antibody was performed from each fraction after Iodixanol separation at time 0and after 1and 4h of chase. 

Phrase: "In C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "immunoprecipitation with J27 antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed from each fraction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0884358:Performed [Functional Concept]
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "after Iodixanol separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036679:Separation [Pathologic Function]
   861   C0237868:Separation [Social Behavior]
   861   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "at time 0and"

Phrase: "after 1and 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292426:4H [Temporal Concept]

Phrase: "of chase."
Processing 00000000.tx.154: Note that the distributions of both WT PS1 and E9 holoprotein were not substantially changed during 0-4 h of chase. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the distributions of both WT PS1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0037775:Distributions [Spatial Concept]
   711 E C0520511:distribution [Idea or Concept]
   711 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "E9 holoprotein"

Phrase: "were"

Phrase: "not substantially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "changed during 0-4 h of chase."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0392747:Changed [Functional Concept]
   748   C0441932:H+ [Classification]
   748   C0443172:Changed [Quantitative Concept]
   748   C0564385:/h [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.155: The gradient fractions showed that the longer half-life of E9 was due primarily to diminished turnover of protein in the ER fractions. 

Phrase: "The gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the longer half-life of E9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0018517:Half-Life [Temporal Concept]
   787   C0023980:Length of Life [Temporal Concept]
           life length
   753   C0376558:Life [Idea or Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "due primarily to diminished turnover of protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0597297:Protein Turnover [Molecular Function]
   774   C0678226:Due to [Functional Concept]
           due
   748   C0031227:turnover [Quantitative Concept]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205216:Diminished [Quantitative Concept]
   748   C0243127:turnover [Functional Concept]
   748   C0443331:Turnover [Health Care Activity]
   748   C3146286:Due [Idea or Concept]

Phrase: "in the ER fractions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]
Processing 00000000.tx.156: The distribution of NTF (arrowhead) in PS1 WT cells was shifted from the dense to lighter fractions during the chase period (top). 

Phrase: "The distribution of NTF (arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: ")"

Phrase: "in PS1 WT cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   823   C0449475:type cell [Intellectual Product]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "shifted from the dense to lighter fractions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0333051:shifted [Functional Concept]
   748   C0336769:Lighter [Manufactured Object]
   748   C0439794:Dense [Qualitative Concept]
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]
   714 E C2347509:Shift [Phenomenon or Process]

Phrase: "during the chase period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.157: NTF derived from endogenous PS1 in E9 cells did not appear until the 4h time point (bottom). 

Phrase: "NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "derived from endogenous PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0205227:Endogenous [Functional Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "in E9 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear until the 4h time point"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0700364:APPEAR [Qualitative Concept]
   753   C1292426:4H [Temporal Concept]
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.158: Closer inspection of the NTF generated during the pulse-chase period showed that at time 0,small amounts of labeled NTF can be detected in the PS1 WT cell line (Fig. 5C). 

Phrase: "Closer inspection of the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0199219:Inspection [Functional Concept]

Phrase: "generated during the pulse-chase period"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0439531:/period [Temporal Concept]
   753   C1947910:Pulse [Phenomenon or Process]
   753   C1948053:Period [Temporal Concept]
   753   C3146294:Generated [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that at time 0,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "small amounts of labeled NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected in the PS1 WT cell line"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   764   C0007600:Cell Line [Cell]
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0449475:type cell [Intellectual Product]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   764   C1883559:Wild Type [Organism Attribute]
   762 E C0007634:Cell Type [Cell]
           Cell
   762   C0441729:Type 1 [Classification]
   742   C0205132:Line [Spatial Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C0445392:Wild [Intellectual Product]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1269647:Cell [Cell]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1547052:*Type [Quantitative Concept]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.159: Surprisingly, at this time point, the distribution of NTF was virtually identical to the full-length protein, i.e. with the peak signal in fractions 3and 4.

Phrase: "Surprisingly,"

Phrase: "at this time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "the distribution of NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "virtually identical to the full-length protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with the peak signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "in fractions 3and 4."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.160: After 1h of chase, the levels of labeled NTF were increased and were distributed more widely, extending into the lighter fractions. 

Phrase: "After 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "of chase,"

Phrase: "the levels of labeled NTF"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "more widely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "extending into the lighter fractions."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0336769:Lighter [Manufactured Object]
   760   C0439792:Extending [Spatial Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C0231448:Extend [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.161: Finally, after 4h of chase, labeled NTF was predominantly within the Golgi-enriched fractions, similar to that seen at the steady state conditions. 

Phrase: "Finally,"

Phrase: "after"

Phrase: "4h of chase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292426:4H [Temporal Concept]

Phrase: "labeled NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "predominantly within the Golgi-enriched fractions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0018042:Golgi [Cell Component]
   753   C0359583:enriched [Food]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen at the steady state conditions."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0678587:steady state [Natural Phenomenon or Process]
   753   C0205361:Steady [Qualitative Concept]
   753   C0205397:Seen [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719   C0012634:condition [Disease or Syndrome]
   719 E C0042789:see [Organism Function]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]
   719 E C1947903:See [Activity]
Processing 00000000.tx.162: These findings indicated that the initial cleavage of PS1 occurred in the ER and the proteolytic fragments were subsequently transported to the Golgi. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the initial cleavage of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "occurred in the ER"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "the proteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "transported to the Golgi."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C1550030:Transport To [Idea or Concept]
   770   C0018042:Golgi [Cell Component]
   737   C0005528:Transport, NOS [Cell Function]
   737   C1317949:Transport [Manufactured Object]
   737   C3495449:transport [Medical Device]
Processing 00000000.tx.163: Similar localization of labeled NTF to the Golgi fractions was seen in E9 cell line at the 4-h chase time, representing fragments derived from endogenous PS1 (Fig. 5C). 

Phrase: "Similar localization of labeled NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "to the Golgi fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "seen in E9 cell line"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0007600:Cell Line [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:Line [Spatial Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "at the 4-h chase time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:Time [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from endogenous PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0205227:Endogenous [Functional Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.164: Interestingly, endogenous NTF in the E9 cell line was not visible until the 4-h time point, suggesting a delay in the formation of this proteolytic species.  

Phrase: "Interestingly,"

Phrase: "endogenous NTF in the E9 cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "not visible until the 4-h time point,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205379:Visible [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a delay in the formation of this proteolytic species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205421:Delay [Temporal Concept]
Processing 00000000.tx.165: DISCUSSION Top Abstract Introduction Materials & Methods Results Discussion References The mechanisms by which mutations in PS1 and PS2 result in the early onset of the AD phenotype are unclear. 

Phrase: "DISCUSSION Top Abstract Introduction Materials & Methods Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The mechanisms by which mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "in PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2 result in the early onset of the AD phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.166: It is hypothesized that the selective increase in the production and release of the amyloidogenic A42 as a result of the presenilin mutations is a key factor in the pathogenesis of FAD (10, 23-26). 

Phrase: "It"

Phrase: "is"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the selective increase in the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "release of the amyloidogenic A42"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of the presenilin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a key factor in the pathogenesis of FAD (10,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0960756:factor A [Organic Chemical]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "23-26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.167: At present, the intracellular compartment where presenilin interacts directly or indirectly with APP is unknown. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the intracellular compartment where presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interacts"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.168: In this study, we analyzed the subcellular distribution of presenilins in transfected cells. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the subcellular distribution of presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.169: Our results showed that PS1 and PS2 are similarly distributed, with holoproteins being principally located in the ER, while the stable PS1 and PS2 fragments were principally located in the Golgi. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "similarly"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: ","

Phrase: "with holoproteins"

Phrase: "being"

Phrase: "principally"

Phrase: "located in the ER,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "while"

Phrase: "the stable PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2 fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "were"

Phrase: "principally"

Phrase: "located in the Golgi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018042:Golgi [Cell Component]
Processing 00000000.tx.170: The E9 PS1 mutation results in a broader distribution of the protein in both ER and Golgi-rich fractions as well as a prolonged turnover rate due to diminished degradation within the ER. 

Phrase: "The E9 PS1 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "results in a broader distribution of the protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0872250:protein distribution [Cell Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0520511:distribution [Idea or Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]
   744   C2825142:Result [Finding]
   711   C0332464:Broad [Spatial Concept]

Phrase: "in both ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi-rich fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "as well as"

Phrase: "a prolonged turnover rate due to diminished degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "within the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.171: Our results also indicate that endoproteolysis to generate stable N- and C-terminal fragments occurs in the ER. 

Phrase: "Our results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that endoproteolysis to"

Phrase: "generate"

Phrase: "stable N-"

Phrase: "and"

Phrase: "C-terminal fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "occurs in the ER."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.172: Previous immunolocalization studies of transfected cells demonstrated that both PS1 and PS2 are located in the ER and Golgi (13, 14). 

Phrase: "Previous immunolocalization"

Phrase: "studies of transfected cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "located in the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.173: These studies, however, could not distinguish the signals derived from full-length protein versus stable NTFs and CTFs. 

Phrase: "These studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "distinguish"

Phrase: "the signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "derived from full-length protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0443225:Full [Qualitative Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]
   760   C3245521:derived [Idea or Concept]

Phrase: "versus"

Phrase: "stable NTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTFs."
Processing 00000000.tx.174: We therefore carried out subcellular fractionations of CHO and 293cells stably transfected with PS1 or PS2 to determine the localization of full-length presenilin and its fragments. 

Phrase: "We therefore"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out subcellular fractionations of CHO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1656251:subcellular fractionation [Laboratory Procedure]
   714   C0016640:fractionation [Laboratory Procedure]
   714   C0524811:fractionation [Therapeutic or Preventive Procedure]
   714   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "293cells stably"

Phrase: "transfected with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "PS2 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418986:PRESENILIN 2 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "determine"

Phrase: "the localization of full-length presenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "its fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.175: Our results showed that full-length PS1 and PS2 were distributed in dense fractions that colocalized with the ER marker, calnexin. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "distributed in dense fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439794:Dense [Qualitative Concept]
   770   C1264633:Fractions [Quantitative Concept]
   770   C1704711:Distributed [Functional Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "colocalized with the ER marker,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0005516:Marker [Clinical Attribute]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "calnexin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108187:Calnexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413107:CALNEXIN [Gene or Genome]
Processing 00000000.tx.176: Both stable NTF and CTF were distributed predominantly in the lighter fractions that colocalized with the Golgi marker, -galactosyltransferase activity. 

Phrase: "Both stable NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "predominantly in the lighter fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0336769:Lighter [Manufactured Object]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "colocalized with the Golgi marker, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005516:Marker [Clinical Attribute]
   760   C0018042:Golgi [Cell Component]

Phrase: "galactosyltransferase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1152102:galactosyltransferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.177: In these gradient fractions, the ER and Golgi fractions overlapped with each other and did not represent distinct populations. 

Phrase: "In these gradient fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "overlapped with each other"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0185027:overlapped [Therapeutic or Preventive Procedure]
   737 E C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "distinct populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.178: We also cannot exclude the possibility of other organelles containing presenilins that may co-purify into same gradient fractions. 

Phrase: "We also"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of other organelles"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "may"

Phrase: "co-purify into same gradient fractions."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.179: Therefore, our studies can only determine the predominant localization of these presenilin protein species to these compartments. 

Phrase: "Therefore,"

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "determine"

Phrase: "the predominant localization of these presenilin protein species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597704:protein localisation [Cell Function]
   767   C1159772:Protein Localization [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "to these compartments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1185625:Compartments [Body Space or Junction]
  1000   C1382196:Compartments [Natural Phenomenon or Process]
   966 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.180: Lesser amounts of protein in other locations cannot be excluded, nor did we examine the nuclear localization of the presenilins as was reported recently (27). 

Phrase: "Lesser amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "in other locations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0450429:locations [Spatial Concept]
   966 E C1515974:Location [Body Location or Region]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ","

Phrase: "nor"

Phrase: "did"

Phrase: "we"

Phrase: "examine"

Phrase: "the nuclear localization of the presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "as"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.181: Nonetheless, the clear subcellular separation between the full-length presenilins and the stable fragments is noteworthy, because it is not known whether the normal physiological function of presenilin is provided by full-length molecules or proteolytic fragments. 

Phrase: "Nonetheless,"

Phrase: "the clear subcellular separation between the full-length presenilins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0036679:Separation [Pathologic Function]
   742   C0237868:Separation [Social Behavior]
   742   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "the stable fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "noteworthy,"

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "the normal physiological function of presenilin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "provided by full-length molecules"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0443225:Full [Qualitative Concept]
   760   C0567416:molecules [Substance]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]
   760   C1999230:Provided [Activity]

Phrase: "or"

Phrase: "proteolytic fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.182: In our study, the subcellular distributions for two PS1 mutations (M146L and C410Y) and the N141I PS2 mutation were similar to each other and to the respective WT presenilins. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the subcellular distributions for two PS1 mutations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0037775:Distributions [Spatial Concept]
   711 E C0520511:distribution [Idea or Concept]
   711 E C1704711:Distribution [Functional Concept]

Phrase: "(M146L"

Phrase: "and"

Phrase: "C410Y"

Phrase: ")"

Phrase: "and"

Phrase: "the N141I PS2 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "similar to each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and to the respective WT presenilins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   748   C1515981:And [Idea or Concept]
   748   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.183: Therefore, most mutations do not overtly alter presenilin trafficking. 

Phrase: "Therefore,"

Phrase: "most mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "do"

Phrase: "not overtly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.184: In contrast, the noncleavable E9 PS1 mutant was localized to a larger number of gradient fractions, being distributed to both ER and Golgi fractions. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the noncleavable E9 PS1 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "localized to a larger number of gradient fractions,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   793   C0454266:Number of fractions [Quantitative Concept]
   750   C1264633:Fraction of [Quantitative Concept]
           Fractions
   750   C1264664:*Number Fraction [Quantitative Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0392752:Localized [Spatial Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0443228:larger [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0549177:Larger [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]
   744   C1704243:Larger [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "being"

Phrase: "distributed to both ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "Golgi fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.185: In addition, as was shown recently (22), pulse-chase studies showed that the turnover rate of E9 mutant protein was considerably slower than WT PS1 holoprotein. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "as"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "pulse-chase studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the turnover rate of E9 mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "considerably slower than WT PS1 holoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0439834:Slow [Qualitative Concept]
Processing 00000000.tx.186: We initially speculated that the transport of E9 to the Golgi compartment where the stable presenilin fragments are located may underlie the decrease in turnover rate of this mutant protein species. 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "speculated"

Phrase: "that"

Phrase: "the transport of E9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "to the Golgi compartment where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "the stable presenilin fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "located"

Phrase: "may"

Phrase: "underlie"

Phrase: "the decrease in turnover rate of this mutant protein species."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.187: However, pulse-chase labeling combined with subcellular fractionation showed that a significant pool of pulse-labeled E9 protein remained intact within the ER at a time when WT PS1 holoprotein was completely degraded. 

Phrase: "However,"

Phrase: "pulse-chase labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1167624:Labeling [Mental Process]
   827   C1947902:Labeling [Manufactured Object]
   827   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "combined with subcellular fractionation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1656251:subcellular fractionation [Laboratory Procedure]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0205195:Combined [Qualitative Concept]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a significant pool of pulse-labeled E9 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0337051:Pool [Geographic Area]
   744   C1509144:pool [Clinical Attribute]
   744   C2349200:Pool [Functional Concept]

Phrase: "remained"

Phrase: "intact within the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205266:Intact [Qualitative Concept]
   760   C1554187:Intact [Idea or Concept]

Phrase: "at a time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "when"

Phrase: "WT PS1 holoprotein"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.188: This result suggests that reduced proteolytic degradation of E9 within the ER is responsible for the increased half-life of this molecule. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that reduced proteolytic degradation of E9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "within the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "is"

Phrase: "responsible for the increased half-life of this molecule."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]
Processing 00000000.tx.189: In time, a small fraction of undegraded protein, together with the endogenous NTF and CTF, are found in the Golgi compartment. 

Phrase: "In time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "a small fraction of undegraded protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]

Phrase: "together with the endogenous NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "found in the Golgi compartment."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0018042:Golgi [Cell Component]
   760   C0150312:Found [Quantitative Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.190: Previous studies have consistently shown an inverse relationship between E9 expression and endogenous NTF levels (22, 26), suggesting that mutant holoprotein competes with the normal cleavage of endogenous PS1. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "consistently"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an inverse relationship between E9 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "endogenous NTF levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(22,"

Phrase: "26"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mutant holoprotein"

Phrase: "competes with the normal cleavage of endogenous PS1."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   742   C0010813:cleavage [Cell Function]
   742   C0205227:Endogenous [Functional Concept]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1330957:cleavage [Cell Function]
   742   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.191: In this study, increasing expression of E9 mutant protein by muristerone A induction similarly led to progressively lower levels of endogenous PS1 stable fragments. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "expression of E9 mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by muristerone A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A induction similarly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to progressively lower levels of endogenous PS1 stable fragments."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0456947:Level 1 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.192: Interestingly, in the pulse-chase/fractionation studies, the appearance of labeled endogenous fragments was delayed. 

Phrase: "Interestingly,"

Phrase: "in the pulse-chase/fractionation studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "the appearance of labeled endogenous fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "was"

Phrase: "delayed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]
Processing 00000000.tx.193: Therefore, production of NTF from proteolysis of endogenous PS1 is affected both quantitatively and kinetically in the presence of E9 mutant protein. 

Phrase: "Therefore,"

Phrase: "production of NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "from proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "of endogenous PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "both quantitatively"

Phrase: "and"

Phrase: "kinetically in the presence of E9 mutant protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.194: This competition is likely to occur in the ER, because E9 appeared to be largely degraded in this compartment. 

Phrase: "This competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679932:competition [Social Behavior]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "occur in the ER,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "because"

Phrase: "E9"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "largely"

Phrase: "degraded in this compartment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1185625:Compartment [Body Space or Junction]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.195: Our study also provides evidence that constitutive endoproteolysis of PS1 to generate stable NTF and CTF occurs in the ER. 

Phrase: "Our study also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that constitutive endoproteolysis of PS1 to"

Phrase: "generate"

Phrase: "stable NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "occurs in the ER."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.196: Pulse-chase experiments combined with subcellular fractionation showed that the initial pool of labeled NTF, albeit in very low levels, was located predominantly in the ER fractions, similar to labeled holoprotein. 

Phrase: "Pulse-chase experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "combined with subcellular fractionation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1656251:subcellular fractionation [Laboratory Procedure]
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0205195:Combined [Qualitative Concept]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the initial pool of labeled NTF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "albeit in very low levels,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0442811:Very low [Finding]
   760   C0205251:low [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "located"

Phrase: "predominantly in the ER fractions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "similar to labeled holoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.197: During the chase period, however, the amount of labeled NTF increased, consistent with a precursor-product relationship between full-length protein species and their fragments within the ER. 

Phrase: "During the chase period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "however,"

Phrase: "the amount of labeled NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "consistent with a precursor-product relationship"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "between full-length protein species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "their fragments within the ER."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.198: Importantly, the NTF was seen to distribute to lighter fractions during the chase. 

Phrase: "Importantly,"

Phrase: "the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distribute [Functional Concept]

Phrase: "to lighter fractions during the chase."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.199: By 4h of chase, labeled NTF was distributed predominantly to the Golgi-enriched fractions, similar to that seen at steady state. 

Phrase: "By 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "of chase,"

Phrase: "labeled NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "predominantly to the Golgi-enriched fractions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0018042:Golgi [Cell Component]
   753   C0359583:enriched [Food]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen at steady state."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0678587:steady state [Natural Phenomenon or Process]
   770   C0205361:Steady [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C1301808:State [Geographic Area]
   770   C1442792:State [Functional Concept]
   770   C3148680:State [Geographic Area]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.200: Taken together, these observations provide compelling evidence that constitutive endoproteolysis of PS1 occurs initially in the ER compartment. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that constitutive endoproteolysis of PS1"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "initially in the ER compartment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0205265:Initially [Temporal Concept]
   753   C1185625:Compartment [Body Space or Junction]
   753   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.201: With the notable exception of the E9 mutation, the subcellular distribution of all of the other PS1 (M146L, C410Y) and PS2 (N141I) mutations was indistinguishable from WT PS1 and PS2, respectively. 

Phrase: "With the notable exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "of the E9 mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the subcellular distribution of all of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "other PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(M146L,"

Phrase: "C410Y"

Phrase: ")"

Phrase: "and"

Phrase: "PS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(N141I"

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "indistinguishable from WT PS1"

Phrase: "and"

Phrase: "PS2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively."
Processing 00000000.tx.202: Since all of these presenilin mutations have been reported to show a selective increase in A42 production (10, 17), our results suggest that perturbations in the ER to Golgi processing at this level cannot explain how mutants alter A42 generation. 

Phrase: "Since"

Phrase: "all of these presenilin mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0026882:Mutations [Genetic Function]
   760   C0444868:All [Quantitative Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C3539085:All [Idea or Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a selective increase in A42 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(10,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that perturbations in the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0332453:perturbation [Functional Concept]

Phrase: "to Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "processing at this level"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C1709694:Processing [Activity]
   770   C2946261:Level [Pharmacologic Substance]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
   737 E C1522240:Process [Phenomenon or Process]

Phrase: "cannot"

Phrase: "explain"

Phrase: "how mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "A42 generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.203: Like the presenilins, maturation of APP in the exocytic pathway occurs in the ER and Golgi compartments. 

Phrase: "Like the presenilins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "maturation of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1660003:protein maturation [Cell Function]
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]

Phrase: "in the exocytic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "occurs in the ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "Golgi compartments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.204: Thus, colocalization of both APP and presenilins in the same subcellular compartments leads to the possibility of an interaction between these two molecules, as has been reported in transfected cells (15, 17). 

Phrase: "Thus,"

Phrase: "colocalization of both APP"

Phrase: "and"

Phrase: "presenilins in the same subcellular compartments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "leads to the possibility of an interaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1704675:Interaction [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "between these two molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "reported in transfected cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3282337:Cells [Cell]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(15,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.205: Using subcellular fractionation, we have recently detected increased levels of A42 in ER and Golgi fractions of cells expressing mutant presenilins (16). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "subcellular fractionation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "increased levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "Golgi fractions of cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C1264633:Fraction of [Quantitative Concept]
           Fractions
   802   C0805525:Cell fractions [Cell Component]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "expressing"

Phrase: "mutant presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.206: These observations suggest that understanding the molecular interactions between APP and presenilins as well as other proteins within these cellular compartments will be important in resolving the mechanisms of AD pathogenesis.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the molecular interactions between APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0872079:interactions protein [Molecular Function]
   762   C1167622:Molecular Interaction [Molecular Function]
   714   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as well as"

Phrase: "other proteins within these cellular compartments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "will"

Phrase: "be"

Phrase: "important in resolving"

Phrase: "the mechanisms of AD pathogenesis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.207: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.208: Victor Hsu and Rick Mitchell for helpful discussions and technical advice, and Dr. 

Phrase: "Victor Hsu"

Phrase: "and"

Phrase: "Rick Mitchell for helpful discussions"

Phrase: "and"

Phrase: "technical advice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150600:Advice [Health Care Activity]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.209: Alison Goate for E9 cDNA.  

Phrase: "Alison Goate for E9 cDNA."
Processing 00000000.tx.210: FOOTNOTES * This work was supported by National Institutes of Health Grants AG 12376and NS 01812(to E.H.K.) 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grants AG 12376and NS 01812"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   738   C0018173:Grants [Quantitative Concept]
   738   C0018684:Health [Idea or Concept]
   738   C0021622:Institutes [Organization]
   738   C1521721:Supported [Conceptual Entity]
   738   C3245503:national [Intellectual Product]
   704 E C0183683:Support [Medical Device]
   704 E C1272753:Institute [Idea or Concept]
   704 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to E.H.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"
Processing 00000000.tx.211: and AG 05134and AG 12749 (to D.J.S.), an AFAR Beeson Award (to E.H.K.), and Grants-in-Aid for Scientific Research on Priority Areas (to H.M.).

Phrase: "and"

Phrase: "AG 05134and AG 12749"

Phrase: "("

Phrase: "to D.J.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "an AFAR Beeson Award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004446:Award [Manufactured Object]

Phrase: "("

Phrase: "to E.H.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Grants-in-Aid for Scientific Research"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0260206:Research Grants [Research Activity]
   753   C0018173:Grants [Quantitative Concept]
   753   C0018896:Aid [Social Behavior]
   753   C0449435:Aid [Manufactured Object]
   753   C3540469:AID [Gene or Genome]
   719 E C1548284:Grant [Idea or Concept]

Phrase: "on Priority Areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "("

Phrase: "to H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ")."
Processing 00000000.tx.212: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.213: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.214: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.215: ** To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.216: Present address: Dept. of Neurosciences 0691,University of California San Diego, La Jolla, CA 92093-0691. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neurosciences 0691,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027910:Neurosciences [Biomedical Occupation or Discipline]
   827 E C1552241:Neuroscience [Professional or Occupational Group]
   827 E C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "University of California San Diego,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0006754:California [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C1826357:San [Gene or Genome]
   804   C3146274:California [Plant]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92093-0691."
Processing 00000000.tx.217: 1 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.218: FAD, familial Alzheimer's disease; 

Phrase: "FAD,"

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.219: PS1, presenilin-1; 

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.220: PS2, presenilin-2; 

Phrase: "PS2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "presenilin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.221: ER, endoplasmic reticulum; 

Phrase: "ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ";"
Processing 00000000.tx.222: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.223: WT, wild type; 

Phrase: "WT, wild type"

Phrase: ";"
Processing 00000000.tx.224: E9, PS1 mutant lacking exon 9; 

Phrase: "E9,"

Phrase: "PS1 mutant lacking exon 9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PRESENILIN 1 [Gene or Genome]
   799   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0332268:Lacking [Qualitative Concept]
   799   C0596988:Mutant [Cell or Molecular Dysfunction]
   799   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.225: A, amyloid -peptide; 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A,"

Phrase: "amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.226: NTF, N-terminal endoproteolytic fragment; 

Phrase: "NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "N-terminal endoproteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.227: CTF, C-terminal endoproteolytic fragment; 

Phrase: "CTF,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "C-terminal endoproteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.228: CHO, Chinese hamster ovary.  

Phrase: "CHO,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "Chinese hamster ovary."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.229: REFERENCES Top Abstract Introduction Materials & Methods Results Discussion References Selkoe, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials & Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.230: J. 

Phrase: "J."
Processing 00000000.tx.231: (1997) Science 275, 630-631[Free FullText] Sherrington, R., Rogaev, E. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "630-631"

Phrase: "[Free FullText"

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.232: I., Liang, Y., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.233: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J."
Processing 00000000.tx.234: -F., Bruni, A. 

Phrase: "-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.235: C., Montesi, M. 

Phrase: "C., Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."
Processing 00000000.tx.237: A., Roses, A. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.238: D., Fraser, P. 

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.239: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.240: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.241: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.242: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.243: (1995) Nature 375, 754-760[CrossRef][Medline] [OrderarticleviaInfotrieve] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.244: M., Oshima, J., Pettingell, H., Yu, C., Jondro, P. 

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.245: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.246: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.247: C., Fu, Y. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.248: -H., Guenette, S. 

Phrase: "-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.249: Y., Galas, D., Nemens, E., Wijsman, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.250: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.251: D., Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.252: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.253: E. 

Phrase: "E."
Processing 00000000.tx.254: (1995) Science 269, 973-977[Medline] [OrderarticleviaInfotrieve] Rogaev, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973-977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rogaev,"

Phrase: "E."
Processing 00000000.tx.255: I., Sherrington, R., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.256: A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holamn, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holamn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piacentini,"

Phrase: "S."

Phrase: ","

Phrase: "Amaducci,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cohen,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.257: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.258: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.259: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.260: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.261: (1995) Nature 376, 775-778[CrossRef][Medline] [OrderarticleviaInfotrieve] Baumeister, R., Leimer, U., Zweckbronner, I., Jakubek, C., Grunberg, J., and Haass, C. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 376,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "775-778"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Baumeister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Leimer,"

Phrase: "U.,"

Phrase: "Zweckbronner,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jakubek,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.262: (1997) Genes Function 1, 149-159[Medline] [OrderarticleviaInfotrieve] Levitan, D., Doyle, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "Function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "149-159"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levitan,"

Phrase: "D."

Phrase: ","

Phrase: "Doyle,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.263: G., Brousseau, D., Lee, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brousseau,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.264: K., Thinakaran, G., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.265: H., Sisodia, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.266: S., and Greenwald, I. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.267: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.268: Natl. 

Phrase: "Natl."
Processing 00000000.tx.269: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.270: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.271: U.S.A. 

Phrase: "U.S.A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1704253:U Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0041703:U S [Geographic Area]

Phrase: "A."
Processing 00000000.tx.272: 93, 14940-14944[Abstract/Free FullText] Doan, A., Thinakaran, G., Borchelt, D. 

Phrase: "93,"

Phrase: "14940-14944"

Phrase: "[Abstract/Free FullText"

Phrase: "] Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.273: R., Slunt, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.274: H., Ratovitski, T., Podlisny, M., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Podlisny,"

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.275: J., Seeger, M., Gandy, S. 

Phrase: "J.,"

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.276: E., Price, D. 

Phrase: "E.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.277: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.278: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.279: (1996) Neuron 17, 1023-1030[Medline] [OrderarticleviaInfotrieve] Lehmann, S., Chiesa, R., and Harris, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1023-1030"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lehmann,"

Phrase: "S."

Phrase: ","

Phrase: "Chiesa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Harris,"

Phrase: "D."
Processing 00000000.tx.280: A. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.281: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.282: Biol. 

Phrase: "Biol."
Processing 00000000.tx.283: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.284: 272, 12047-12051[Abstract/Free FullText] Podlisny, M. 

Phrase: "272,"

Phrase: "12047-12051"

Phrase: "[Abstract/Free FullText"

Phrase: "] Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.285: B., Citron, M., Amarante, P., Sherrington, R., Xia, W., Zhang, J., Diehl, T., Levesque, G., Fraser, P., Haass, C., Koo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.286: H.M., Seubert, P., St. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.287: George-Hyslop, P., Teplow, D. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.288: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: (1997) Neurobiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.291: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.292: 3, 325-337[CrossRef][Medline] [OrderarticleviaInfotrieve] Xia, W., Zhang, J., Kholodenko, D., Citron, M, Podlisny, M. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "325-337"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.293: B., Teplow, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.294: B., Haass, C., Seubert, P., Koo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.295: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.296: J. 

Phrase: "J."
Processing 00000000.tx.297: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.298: Biol. 

Phrase: "Biol."
Processing 00000000.tx.299: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.300: 272, 7977-7982[Abstract/Free FullText] Kim, T.-W., Pettingell, W. 

Phrase: "272,"

Phrase: "7977-7982"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "T.-W., Pettingell,"

Phrase: "W."
Processing 00000000.tx.301: H., Hallmark, O. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hallmark,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.302: G., Moir, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.303: D., Wasco, W., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.304: E. 

Phrase: "E."
Processing 00000000.tx.305: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.306: Biol. 

Phrase: "Biol."
Processing 00000000.tx.307: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.308: 272, 11006-11010[Abstract/Free FullText] Thinakaran, G., Borchelt, D. 

Phrase: "272,"

Phrase: "11006-11010"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.309: R., Lee, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.310: K., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.311: H., Spitzer, L., Kim, G., Rotovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spitzer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rotovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.312: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.313: E., Jenkins, N. 

Phrase: "E.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.314: A., Copeland, N. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.315: G., Price, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.316: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.317: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.318: (1996) Neuron 17, 181-190[Medline] [OrderarticleviaInfotrieve] Kovacs, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kovacs,"

Phrase: "D."
Processing 00000000.tx.319: M., Fausett, H. 

Phrase: "M."

Phrase: ","

Phrase: "Fausett,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.320: J., Page, K. 

Phrase: "J.,"

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.321: J., Kim, T.-W., Moir, R. 

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "T.-W., Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.322: D., Merriam, D. 

Phrase: "D."

Phrase: ","

Phrase: "Merriam,"

Phrase: "D."
Processing 00000000.tx.323: E., Hollister, R. 

Phrase: "E.,"

Phrase: "Hollister,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.324: D., Hallmark, O. 

Phrase: "D."

Phrase: ","

Phrase: "Hallmark,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.325: G., Mancini, R., Felsenstein, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mancini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Felsenstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.326: M., Human, B. 

Phrase: "M."

Phrase: ","

Phrase: "Human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.327: T., Tanzi, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: E., and Wasco, W. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.329: (1996) Nature Med. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature Med."
Processing 00000000.tx.330: 2, 224-229[Medline] [OrderarticleviaInfotrieve] De Strooper, B., Beullens, M., Contreras, B., Levesque, L., Craessaerts, K., Cordell, B., Moechars, D., Bollen, M., Fraser, P., St. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "224-229"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Beullens,"

Phrase: "M."

Phrase: ","

Phrase: "Contreras,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Cordell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Bollen,"

Phrase: "M."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.331: George-Hyslop, P., and Van Leuven, F. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.332: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.333: Biol. 

Phrase: "Biol."
Processing 00000000.tx.334: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.335: 272, 3590-3598[Abstract/Free FullText] Weidemann, A., Paliga, K., Durrwang, U., Czech, C., Evin, G., Masters, C. 

Phrase: "272,"

Phrase: "3590-3598"

Phrase: "[Abstract/Free FullText"

Phrase: "] Weidemann,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3284170:Paliga [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Durrwang,"

Phrase: "U.,"

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Evin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.336: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.337: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.338: Med. 

Phrase: "Med."
Processing 00000000.tx.339: 3, 328-332[Medline] [OrderarticleviaInfotrieve] Xia, W., Zhang, J., Ostaszewski, B., Seubert, P., Koo, E. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "328-332"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Ostaszewski,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.340: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.341: J. 

Phrase: "J."
Processing 00000000.tx.342: (1997) Soc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Soc."
Processing 00000000.tx.343: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.344: Abstr. 

Phrase: "Abstr."
Processing 00000000.tx.345: 23, 294 Xia, W., Zhang, J., Perez, R., Koo, E. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "294 Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Perez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.346: H., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.347: J. 

Phrase: "J."
Processing 00000000.tx.348: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.349: Natl. 

Phrase: "Natl."
Processing 00000000.tx.350: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.351: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.352: U.S.A. 

Phrase: "U.S.A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1704253:U Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0041703:U S [Geographic Area]

Phrase: "A."
Processing 00000000.tx.353: 94, 8208-8213[Abstract/Free FullText] Okochi, M., Ishii, K., Usami, M., Sahara, N., Kametani, F., Tanaka, K., Fraser, P. 

Phrase: "94,"

Phrase: "8208-8213"

Phrase: "[Abstract/Free FullText"

Phrase: "] Okochi,"

Phrase: "M."

Phrase: ","

Phrase: "Ishii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Usami,"

Phrase: "M."

Phrase: ","

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kametani,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.354: E., Ikeda, M., Saunders, A. 

Phrase: "E.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.355: M., Hendriks, L., Shoji, S. 

Phrase: "M."

Phrase: ","

Phrase: "Hendriks,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Shoji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.356: I., Nee, L. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nee,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.357: E., Martin, J. 

Phrase: "E.,"

Phrase: "Martin,"

Phrase: "J."
Processing 00000000.tx.358: J., VanBroeckhoven, C., St. 

Phrase: "J.,"

Phrase: "VanBroeckhoven,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.359: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: H., Roses, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.361: D., and Mori, H. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Mori,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.362: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.363: 418, 162-166[CrossRef][Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "418,"

Phrase: "162-166"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.364: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.365: H., Hoffman, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hoffman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: N., Perry, G., and Price, D. 

Phrase: "N., Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.367: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.368: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.369: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.370: 13, 3136-3142[Abstract] Bretz, R., and Staubli, W. 

Phrase: "13,"

Phrase: "3136-3142"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bretz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Staubli,"

Phrase: "W."
Processing 00000000.tx.371: (1977) Eur. 

Phrase: "(1977"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.372: J.

Phrase: "J."
Processing 00000000.tx.373: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.374: 77, 181-192[Medline] [OrderarticleviaInfotrieve] Le, A., Steiner, J. 

Phrase: "77,"

Phrase: "181-192"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Le,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439090:LE [Idea or Concept]
  1000   C1423767:LE [Gene or Genome]

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Steiner,"

Phrase: "J."
Processing 00000000.tx.375: L., Ferrell, G. 

Phrase: "L., Ferrell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.376: A., Shaker, J. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Shaker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687735:Shaker [Population Group]

Phrase: "J."
Processing 00000000.tx.377: C., and Sifers, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Sifers,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.378: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.379: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.380: Biol. 

Phrase: "Biol."
Processing 00000000.tx.381: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.382: 269, 7514-7519[Abstract/Free FullText] Ratovitski, T., Slunt, H. 

Phrase: "269,"

Phrase: "7514-7519"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.383: H., Thinakaran, G., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.384: L., Sisodia, S. 

Phrase: "L., Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.385: S., and Borchelt, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.386: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.387: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.388: Biol. 

Phrase: "Biol."
Processing 00000000.tx.389: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.390: 272, 24536-24541[Abstract/Free FullText] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "272,"

Phrase: "24536-24541"

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.391: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.392: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.393: Med. 

Phrase: "Med."
Processing 00000000.tx.394: 2, 864-870[Medline] [OrderarticleviaInfotrieve] Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zehr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.395: -M., Perez-tur, J., Hutton, M., Buee, L., Hairgaya, Y., Morgan, D., Gordon, M. 

Phrase: "-"

Phrase: "M."

Phrase: ","

Phrase: "Perez-tur,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hairgaya,"

Phrase: "Y.,"

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Gordon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.396: N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. 

Phrase: "N., Holcomb,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Refolo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zenk,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.397: (1996) Nature 383, 710-713[CrossRef][Medline] [OrderarticleviaInfotrieve] Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George-Hyslop, P., and Selkoe, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 383,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "710-713"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rommens,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.398: J. 

Phrase: "J."
Processing 00000000.tx.399: (1997) Nature Med. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature Med."
Processing 00000000.tx.400: 3, 67-72[Medline] [OrderarticleviaInfotrieve] Borchelt, D. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "67-72"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Borchelt,"

Phrase: "D."
Processing 00000000.tx.401: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.402: B., Lee, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: K., Davenport, F., Ratovitski, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C.-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.404: H., Wang, R., Seeger, M., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Levey,"

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.405: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.406: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.407: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.408: A., Price, D. 

Phrase: "A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.409: L., Younkin, S. 

Phrase: "L., Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.410: G., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.411: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.412: (1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] Li, J., Xu, M., Zhou, H., Ma, J., and Potter, H. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1005-1013"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Xu,"

Phrase: "M."

Phrase: ","

Phrase: "Zhou,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ma,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.413: (1997) Cell 90, 917-927[Medline] [OrderarticleviaInfotrieve] Copyright  1998 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 90,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "917-927"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  1998 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

